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Introduction {#sec1}
============

During development of metazoans, cells progressively lose plasticity and acquire specific fates. Mechanisms that restrict cell plasticity and safeguard the differentiated state remain incompletely understood (reviewed by [@bib35]). Both positive and negative gene regulation are required during specification to maintain cell identities ([@bib2], [@bib9], [@bib35]). Positive regulation by transcription factors (TFs) activates genes that define and maintain cell identities, while negative regulation restricts expression of genes belonging to other cell fates ([@bib2], [@bib9], [@bib35]). For instance, the human zinc finger protein RE1-Silencing Transcription factor prevents expression of neural genes in non-neuronal cells ([@bib22]) by recruiting epigenetic regulators that silence chromatin ([@bib4], [@bib81]). Notably, such repressive chromatin regulators gained importance for cellular reprogramming because they can act as barriers for TF-mediated cell conversion ([@bib6], [@bib19]). Recent examples are the histone chaperones LIN-53 in *Caenorhabditis elegans* (RBBP4/CAF-1P48 in mammals) and Chromatin Assembly Factor 1 (CAF-1) in mouse which promote the formation of repressive chromatin and thereby block cell fate reprogramming ([@bib20], [@bib71], [@bib93]). In contrast, chromatin regulators that are known to be non-repressive and promote gene expression have not been recognized as reprogramming barriers.

In a genetic screen for factors that safeguard cell fates in *C. elegans*, we identified that the histone chaperone FACT (facilitates chromatin transcription), which is essential for maintaining gene expression ([@bib66], [@bib67]), blocks TF-mediated reprogramming of non-neuronal cells into neurons. FACT is a conserved heterodimeric complex consisting of SSRP1 (structure-specific recognition protein 1) and SUPT16H (suppressor of Ty 16 homolog) in mammals ([@bib66], [@bib67]) but has not been studied in *C. elegans*. We discovered a germline-specific FACT isoform and show that FACT is required to maintain the intestinal and germline fate in *C. elegans*. Remarkably, the role of FACT as a reprogramming barrier is conserved, as its depletion in human fibroblasts enhances reprogramming to induced pluripotent stem cells (iPSCs) or neurons. Interestingly, transcriptome analysis (RNA-seq \[RNA sequencing\]) of human fibroblasts revealed that reprogramming-promoting factors, including Sal-like protein 4 (SALL4) ([@bib68], [@bib98]), have increased expression upon FACT depletion. Our findings suggest a more dichotomous role for FACT in gene regulation and imply that positive gene expression regulators contribute to impeding the induction of alternative cell fates. Overall, our study points to an evolutionarily conserved mechanism for safeguarding cell identities and identifies an unknown role for FACT in *C. elegans* and human cells.

Results {#sec2}
=======

Whole-Genome RNAi Screen for Cell Fate-Safeguarding Factors in *C. elegans* {#sec2.1}
---------------------------------------------------------------------------

To reveal factors that safeguard cell identities in *C. elegans*, we challenged all tissues by overexpressing CHE-1, a neuron fate-inducing Zn-finger TF. CHE-1 normally specifies the glutamatergic ASE neuron fate, which is characterized by expression of the GCY-5 chemoreceptor ([Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}A) ([@bib100]). Using previously described transgenic animals that express the ASE neuron fate reporter *gcy-5*::*GFP* and allow ubiquitous CHE-1 expression upon heat shock ([@bib71], [@bib93]), we performed a whole-genome RNA interference (RNAi) screen in hermaphrodite adult worms to examine their F1 progeny for ectopic *gcy-5::GFP* induction upon broad *che-1* overexpression (*che-1*^*oe*^) at the young adult stage. We identified 171 RNAi target genes ([Table S1](#mmc2){ref-type="supplementary-material"}) that allow ectopic *gcy-5::GFP* induction upon depletion and represent different tissues: germline, epidermis, or intestine ([Figures 1](#fig1){ref-type="fig"}B and 1C). These genes are implicated in a variety of biological processes such as proteostasis, mitochondria function, and gene regulation by nuclear factors ([Figures 1](#fig1){ref-type="fig"}D--1F). Interestingly, we identified HMG-3, HMG-4, and SPT-16 that are orthologous to subunits of the essential chromatin remodeler FACT ([@bib34], [@bib82]), as well as other genes known to functionally interact with FACT in other species such as SPT-5, EMB-5 (Spt6), and ISW-1 ([@bib29], [@bib59]) ([Figure 1](#fig1){ref-type="fig"}F). HMG-3 and HMG-4 are orthologs of human SSRP1, while SPT-16 is orthologous to SUPT16H ([Figure 1](#fig1){ref-type="fig"}G). Overall, we did not anticipate that depletion of FACT might promote cell fate conversion since it is primarily known for facilitating transcription rather than repressing ectopic gene expression. We therefore focused on characterizing FACT and the cell fate conversion effects upon its depletion.Figure 1Whole-Genome RNAi Screening Strategy to Identify Cell-Fate-Safeguarding Factors in *C. elegans*(A) Schematic representation: the ASER neuron is labeled by *gcy-5::GFP*. Overexpression of the Zn-Finger TF CHE-1 (*che-1*^oe^) combined with genome-wide RNAi led to discovery of genes preventing ectopic *gcy-5::GFP* induction in adults.(B) Representative images of control animals, GFP induction in germline (*lin-53*, *hmg-3*, *isw-1*, and *hecd-1* RNAi), intestine (*spt-16*, *hmg-4*, *emb-5*, and *spt-5* RNAi), epidermis (*hsp-1* RNAi), or germline and gut simultaneously (*cco-1*). Dashed lines indicate outline of animals. Scale bars represent 20 μm.(C) Percentage of 171 genes whose knockdown allowed ectopic GFP induction in specific tissues.(D) Gene ontology (GO) categories of genes from the screen.(E and F) Proteostasis and FACT protein network based on genes identified in the screen. Network plots are based on known and predicted interactions from STRING (string-db.org) with minimal confidence score of 0.4. FACT complex proteins are highlighted in red.(G) Models of FACT subunits in human and *C. elegans*. Conserved protein domains according to *Pfam* and *InterPro* are indicated: Nlob, N-terminal lobe domain; M24, metallopeptidase family M24; SPT16, FACT complex subunit Spt16p/Cdc68p; Rtt, histone chaperone Rttp106-like; SSRP1,structure-specific recognition protein; HMG, high mobility group box domain.See also [Table S1](#mmc2){ref-type="supplementary-material"}.

Depletion of HMG-3 Allows Germ Cell Reprogramming to Neurons {#sec2.2}
------------------------------------------------------------

RNAi against *hmg-3* allows CHE-1-dependent *gcy-5::GFP* induction in germ cells ([Figure 2](#fig2){ref-type="fig"}A). To exclude the possibility that depletion of HMG-3 causes non-specific de-silencing of transgenic reporters, we performed *hmg-3*^*RNAi*^ in the absence of *che-1*^*oe*^. No changes in expression were detected for either *gcy-5::GFP* ([Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B) or two other reporters previously used to detect transgene de-silencing ([Figures S1](#mmc1){ref-type="supplementary-material"}C and S1D) ([@bib33], [@bib49], [@bib70]), suggesting that *hmg-3*^*RNAi*^ creates permissiveness for CHE-1 to activate its target genes in germ cells. Induction of *gcy-5::GFP* expression by *che-1*^*oe*^ upon *hmg-3*^*RNAi*^ is accompanied by morphological changes of germ cells showing axo-dendritic-like projections ([Figure 2](#fig2){ref-type="fig"}A), indicating that germ cells converted into neuron-like cells. To assess the extent of conversion, we examined the nuclear morphology of converted germ cells and expression of neuronal genes. The *gcy-5*::*GFP*-positive cells display a nuclear morphology resembling neuronal nuclei ([Figure 2](#fig2){ref-type="fig"}A), and expression of pan-neuronal reporter genes, *rab-3::NLS*::*RFP* and *unc-119::GFP* ([@bib91]), further demonstrates a true conversion of germ cells into neuron-like cells ([Figures 2](#fig2){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}E). Moreover, reprogrammed germ cells also express *ift-20::NLS::RFP*, a marker for ciliated neurons such as ASE, and the ASE and AWC-specific reporter *ceh-36::GFP* ([@bib40][,]{.ul} [@bib41]) ([Figures 2](#fig2){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}E). Importantly, transgene reporter expression reflects the endogenous expression of neuronal genes as shown by smFISH (single molecule fluorescence in situ hybridization). Transcripts from *gcy-5*, *ceh-36*, *rab-3*, *unc-119*, as well as from the conserved synaptic protein-encoding gene *unc-10* (RIM), become expressed in the reprogrammed germ cells and are comparable in level to endogenous neurons ([Figures 2](#fig2){ref-type="fig"}B, 2C, [S1](#mmc1){ref-type="supplementary-material"}F, and S1G). Furthermore, the acquisition of neuronal characteristics is accompanied by the loss of germline marker *pie-1* and germ cell morphology ([Figure S1](#mmc1){ref-type="supplementary-material"}H), corroborating the notion that germ cells convert into ASE neuron-like cells in *hmg-3*^*RNAi*^ animals upon induction of CHE-1 expression.Figure 2HMG-3 Inhibits Reprogramming of Germ Cells to ASE Neurons in *C. elegans*(A) Depletion of *hmg-3* leads to *gcy-5::GFP* induction in germ cells after *che-1*^*oe*^: white arrowheads indicate protrusions resembling neuron-like projections in *gcy-5::GFP*-positive cells. Dashed lines indicate outline of animals. Scale bars represent 20 μm and 5 μm in the magnification. Differential interference contrast (DIC) illustrates germ cell nuclei of *hmg-3*^*RNAi*^ + *che-1*^*oe*^ animals with changed nuclear morphology (stippled boxes mark magnification). Expression of ASE/AWC (*ceh-36*), sensory (*ift-20*), and pan-neuronal fate markers (*rab-3*, *unc-119*) can be detected in animals with *gcy-5::GFP* in the germline (outlined by dashed lines). Asterisk labels the germline distal tip. Scale bars represent 10 μm. For quantification, see [Figure S1](#mmc1){ref-type="supplementary-material"}E.(B) smFISH to detect transcripts derived from endogenous neuronal genes *gcy-5*, *ceh-36*, *rab-3*, *unc-10*, and *unc119* in *hmg-3*^*RNAi*^ germ cells. mRNA molecules are visualized as red dots. Controls were treated with mock hybridizations. Dashed boxes indicate magnified area. smFISH probes are described in [STAR Methods](#sec4){ref-type="sec"}. Scale bars represent 2 μm.(C) Quantification of smFISH hybridization signals (red dots) per GFP-positive cells. For each condition, 20 GFP-positive cells were counted. Ordinary one-way ANOVA was used for statistical analysis. ^∗∗∗∗^, p \< 0.0001. Error bars represent SD.(D and E) Assessment of non-ASE neuron markers after *che-1*^*oe*^-induced germ cell reprogramming in *hmg-3*^RNAi^ animals. (D) Representative images and (E) quantification of non-ASE markers *glr-1::mCherry* (interneurons), *ttr-39::mCherry* (GABAergic neurons), and *ttx-3::mCherry* (cholinergic interneuron) in reprogrammed germ cells (magnifications) expressing *gcy-5::GFP*. Dashed white lines outline the worm, and yellow lines outline the germline. Scale bars represent 20 μm and 5 μm in magnifications. Error bars represent SEM.See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.

Specificity of Germ Cell to Neuron Reprogramming in HMG-3-Depleted Animals {#sec2.3}
--------------------------------------------------------------------------

To examine whether CHE-1 reprograms germ cells in the *hmg-3*^*RNAi*^ germline to properly specified ASE neurons, we tested the expression of markers for other neuron subtypes. CHE-1 does not induce GABAergic or cholinergic neuron reporters in *hmg-3*^*RNAi*^ animals ([Figures 2](#fig2){ref-type="fig"}D and 2E), arguing that reprogrammed germ cells are not mis-specified but acquire a specific glutamatergic ASE fate. We next asked whether *hmg-3* plays a widespread role in preventing germ cell conversion under ectopic expression of TFs. Mis-expression of the GABAergic neuron fate-inducing homeodomain TF UNC-30 ([@bib45]) resulted in germ cell to GABAergic neuron conversion in *hmg-3*^*RNAi*^ animals ([Figures S2](#mmc1){ref-type="supplementary-material"}A--S2C). However, mis-expression of the myogenic TF HLH-1 (MyoD homolog) ([@bib38]) or the intestinal fate-inducing GATA-type TF ELT-7 ([@bib79]) failed to convert germ cells into muscle or gut-like cells, respectively ([Figures S2](#mmc1){ref-type="supplementary-material"}B and S2D). This suggests that *hmg-3*^*RNAi*^ specifically creates permissiveness for germ cell to neuron reprogramming. However, the negative results for HLH-1 and ELT-7 need cautious interpretation, as we cannot exclude the possibility of germline-mediated silencing of the respective transgenes. We tested whether mitotic or meiotic germ cells are susceptible to reprogramming using animals that carry a temperature-sensitive gain-of-function mutation of the Notch receptor GLP-1 (Germ Line Proliferation) that causes loss of meiotic germ cells ([@bib72]). Growth at a non-permissive temperature would lead to a loss of reprogramming if the converting germ cells belong to the meiotic pool. Germ cell conversion is not lost in *glp-1(gf)* mutants, suggesting that mitotic germ cells are the source for reprogramming into neuron-like cells ([Figure S2](#mmc1){ref-type="supplementary-material"}E). This reprogramming is also independent of the cell-cycle activity of germ cells, as blocking cell-cycle progression by hydroxyurea (HU) ([@bib32]) did not inhibit germ cell conversion in *hmg-3*^*RNAi*^ animals ([Figure S2](#mmc1){ref-type="supplementary-material"}F). Taken together, depletion of the SSRP1 ortholog HMG-3 in *C. elegans* allows reprogramming of mitotic germ cells into specific neurons upon expression of neuron fate-inducing TFs.

Other FACT Subunits Prevent Neuron Fate Induction in the Intestine {#sec2.4}
------------------------------------------------------------------

While depletion of *hmg-3* creates permissiveness for germ cell reprogramming, RNAi against *hmg-4* and *spt-16* allows induction of *gcy-5::GFP* in intestinal cells after *che-1*^oe^ ([Figures 3](#fig3){ref-type="fig"}A and 3B). Intestinal cells showing *gcy-5::GFP* expression maintain their original morphological features, indicating an incomplete cell conversion ([Figure 3](#fig3){ref-type="fig"}A). However, smFISH revealed that the *gcy-5*::*GFP*-positive gut cells show expression of neuronal genes as seen in reprogrammed germ cells ([Figures 3](#fig3){ref-type="fig"}C--3E). The lack of morphological changes toward a neuron-like appearance might be due to the structural constraints of the intestine. Nevertheless, intestinal cells switch to a neuronal gene expression profile, which is stably maintained even 2 days after *che-1*^oe^ similar to HMG-3 depletion-mediated germ cell to neuron reprogramming ([Figures S2](#mmc1){ref-type="supplementary-material"}G and S2H). Overall, HMG-4 and SPT-16 prevent the induction of neuronal genes in the intestine, indicating that FACT plays a role in safeguarding cell identities of different tissues in *C. elegans*.Figure 3FACT Subunits HMG-4 and SPT-16 Prevent Neuron Fate Induction in the Intestine(A) RNAi against *hmg-4* and *spt-16* allows *gcy-5::GFP* induction in the intestine. Dashed lines indicate the outline of animals. Scale bars represent 20 μm.(B) Quantification of animals showing *gcy-5::GFP* in the intestine in *che-1*^*oe*^ + *hmg-4*^*RNAi*^ or *spt-16*^*RNAi*^. n indicates the number of animals counted. Error bars represent SEM.(C) Detection of transcripts derived from neuronal genes in *hmg-4*^*RNAi*^ and *spt-16*^*RNAi*^ intestinal cells by smFISH. Individual mRNA molecules are visualized as red dots. Controls were treated with mock hybridizations. Dashed boxes indicate the magnified area. Scale bars represent 2 μm.(D and E) Quantification of smFISH hybridization signals (red dots) per GFP-positive cells. Quantification of neuronal transcripts in the intestine upon (D) *hmg-4* RNAi and (E) *spt-16* RNAi. For each condition, 20 GFP-positive cells were counted. Ordinary one-way ANOVA was used for statistical analysis. ^∗∗^, p \< 0.01, ^∗∗∗^, p \< 0.001, ^∗∗∗∗^, p \< 0.0001. Error bars represent SD.(F and G) Immunostaining of CRISPR-tagged (F) *hmg-3* with HA and (G) *hmg-4* with HA. Dashed lines indicate the outline of the animals. Scale bars represent 20 μm.(H) Anti-SPT-16 immunostaining shows expression in somatic tissues and germline. Dashed lines indicate the outline of the animals. Scale bars represent 20 μm.(I) Tissue-specific FACT isoforms prevent induction of neuronal genes in the germline and intestine.See also [Figure S2](#mmc1){ref-type="supplementary-material"}.

*C. elegans* Has a Germline-Specific FACT Isoform {#sec2.5}
-------------------------------------------------

The tissue-specific effects on ectopic *gcy-5::GFP* induction suggested distinct expression patterns of FACT genes. HMG-3 and HMG-4 share more than 90% amino acid homology with SSRP1 ([@bib34], [@bib82]) and each other. To discriminate between HMG-3 and HMG-4, we tagged both with an HA (Human influenza hemagglutinin) epitope using CRISPR/Cas9 editing. Anti-HA immunostaining revealed that HMG-3 is exclusively expressed in the germline, explaining the distinct effect of *hmg-3*^*RNAi*^ on permissiveness for reprogramming germ cells ([Figure 3](#fig3){ref-type="fig"}F). In contrast, HMG-4 is expressed predominantly in the soma with high intensity in the intestine and has only weak expression in the germline ([Figure 3](#fig3){ref-type="fig"}G). An antibody against SPT-16 revealed expression in all tissues with predominance in the intestine ([Figure 3](#fig3){ref-type="fig"}H). Because *spt-16* RNAi during embryonic development caused early lethality, we could not assay for conversion of germ cells, which requires F1 RNAi as shown for the depletion of *hmg-3* or other previously identified factors ([@bib71], [@bib93]).

Since HMG-4 can be detected with low levels in the germline, we assessed whether the germline-exclusive HMG-3 functions as a bona fide FACT subunit. We immunoprecipitated HMG-3::HA and HMG-4::HA and analyzed co-precipitated proteins by mass spectrometry (immunoprecipitation-mass spectrometry \[IP-MS\]) ([Table S2](#mmc3){ref-type="supplementary-material"}). The most significant interacting protein for both is SPT-16 ([Figures S2](#mmc1){ref-type="supplementary-material"}I and S2J), indicating that they predominantly associate with SPT-16. Notably, *hmg-3* mutant animals (*tm2539*) are sterile and are not rescued by endogenous *hmg-4* and, vice versa, the larval lethality of *hmg-4* mutants (*tm1873*) is not rescued by endogenous *hmg-3*, suggesting non-redundant functions of both proteins.

Collectively, the specific RNAi effects together with the germline-exclusive expression of *hmg-3* suggest that HMG-3 and SPT-16 form a germline-specific FACT that safeguards germ cells, while HMG-4 and SPT-16 form a FACT isoform that safeguards the intestinal fate ([Figure 3](#fig3){ref-type="fig"}I) in *C. elegans*.

FACT Depletion Affects Chromatin Accessibility for Transcription Factors {#sec2.6}
------------------------------------------------------------------------

FACT promotes gene expression by nucleosome reorganization in yeast and human cells (reviewed in [@bib37], [@bib78]); however, in *C. elegans* FACT has not been studied. Therefore, we profiled HMG-3 DNA-binding patterns by ChIP-seq (chromatin immunoprecipitation sequencing), as well as gene expression by RNA-seq and chromatin accessibility using ATAC-seq (Assay for Transposase-Accessible Chromatin sequencing) ([@bib15]) upon FACT depletion. Data derived from this global characterization of FACT is provided in [Figures S3](#mmc1){ref-type="supplementary-material"} and [S4](#mmc1){ref-type="supplementary-material"} and [Tables S2](#mmc3){ref-type="supplementary-material"} and [S3](#mmc4){ref-type="supplementary-material"}.

To clarify why depletion of FACT leads to permissiveness for ectopic fate induction, we focused on chromatin accessibility changes detected by ATAC-seq without inducing *che-1*^*oe*^ (see [STAR Methods](#sec4){ref-type="sec"}) ([Figure 4](#fig4){ref-type="fig"}A). Upon RNAi against *hmg-4* or *spt-16*, average positional patterns of ATAC-seq around promoter-region peaks do not show drastic, uniform changes ([Figure S3](#mmc1){ref-type="supplementary-material"}K), yet similar numbers of total peaks show small but significant increases and decreases (2,770 and 2,768 sites increased and 1,845 and 2,472 sites decreased for *hmg-4*^*RNAi*^ and *spt-16*^*RNAi*^, respectively, FDR \[false discovery rate\], 0.01; see [STAR Methods](#sec4){ref-type="sec"} [Table S3](#mmc4){ref-type="supplementary-material"}). A Spearman correlation of 0,809 of log~2~-fold changes between sites significantly (FDR 0.01) changed upon knockdown of *hmg-4*^*RNAi*^ or *spt-16*^*RNAi*^ suggests that these factors act together, confirming the specificity of the effects ([Figure 4](#fig4){ref-type="fig"}A).Figure 4FACT-Depletion Causes Changes in Chromatin Accessibility and Gene Expression(A) ATAC-seq using isolated nuclei of animals treated with RNAi against FACT subunits. Hexbin density scatterplot of *hmg-4*^*RNAi*^-normalized ATAC-seq log~2~-fold changes plotted against *spt-16*^*RNAi*^-normalized ATAC-seq log~2~-fold changes for ATAC-seq peaks that were significantly differential (FDR 0.01) in at least one of the conditions. Scale shows number of ATAC-seq peaks plotted per hexbin.(B) Key *de novo* generated motifs with matching TFs and enrichment p values from ATAC-seq peaks closing (bottom) or opening (top) upon *hmg-4*^*RNAi*^ or *spt-16*^*RNAi*^.(C) Motif scanning of previously published JUN-1 (top) and ELT-1/-7 (bottom) motifs within sets of ATAC-seq peaks that either decrease (red), increase (green), or do not change (gray; adjusted p value \> 0.5) upon FACT knockdown. Plotted is the maximum motif match score per ATAC-seq peak.(D) RNAi against *hmg-4* or *spt-16* decreases expression of intestinal fate reporters. Dashed lines indicate the outline of the animals. Scale bars represent 20 μm.(E) Quantification of intestinal fate reporter expression from (A). Two-way ANOVA test was used for statistical comparison, ^∗∗∗^ p \< 0.001. At least 200 animals were counted for each condition. Error bars represent SEM.(F) Immunostained intestines from animals treated with RNAi against *hmg-4* and *spt-16* to detect gut-specific ELT-2 and intermediate filament protein IFB-2. Scale bars represent 5 μm.(G) In *jun-1* (*gk557*) mutants, *gcy-5::GFP* induction in gut cells is suppressed. One-tailed Student's t test was used for statistical comparison, ^∗∗∗^ p \< 0.001. At least 150 animals were counted for each condition. Error bars represent SEM.(H) FACT maintains intestinal fate identity and antagonizes JUN-1.(I) Germline-specific P granules are lost upon *hmg-3*^*RNAi*^. Dashed lines outline the germline, and white asterisk indicates the distal tip end of the gonad. Scale bars represent 5 μm.(J) Germ cell fate marker *pie-1::mCherry::his-58* is lost upon *hmg-3*^*RNAi*^*.* Dashed lines outline the germline, white asterisk indicates distal end of the gonad. Scale bars represent 5 μm. At least 150 animals were counted for each condition. Error bars represent SEM. Paired-end Student's t test was used for statistical comparison, ^∗∗∗^ p \< 0.001.(K) FACT maintains germ cell fate identity and antagonizes CHE-1-mediated reprogramming.See also [Figures S3](#mmc1){ref-type="supplementary-material"} and [S4](#mmc1){ref-type="supplementary-material"} and [Tables S3](#mmc4){ref-type="supplementary-material"} and [S6](#mmc1){ref-type="supplementary-material"}.

While decreased accessibility of genomic sites upon FACT depletion is in agreement with the complex's known function as a gene expression activator ([@bib37], [@bib66]), the detection of many increased accessibility sites indicates that FACT may also be required to prevent ectopic gene expression induction, directly or indirectly. This notion is further supported by transcriptome analysis as depletion of *hmg-4*, or *spt-16*, leads to down- but also up-regulation of several genes (1,679 down- and 1,948 up-regulated for *spt-16*^RNAi^) ([Figures S4](#mmc1){ref-type="supplementary-material"}A--S4F). Furthermore, genes with changed expression are enriched for changed ATAC-seq peaks ([Figure S4](#mmc1){ref-type="supplementary-material"}H; see [STAR Methods](#sec4){ref-type="sec"}), suggesting the chromatin landscape and transcriptome concordantly alter, both positively and negatively, upon FACT depletion.

To gain insight into whether chromatin sites that change accessibility upon FACT RNAi are enriched for binding of TF families, we performed *de novo* motif analysis in ATAC-seq peaks, followed by scanning for matching known TF binding preferences (see [STAR Methods](#sec4){ref-type="sec"}) ([Figures 4](#fig4){ref-type="fig"}B, 4C, [S4](#mmc1){ref-type="supplementary-material"}L, and S4M). In *spt-16*^*RNAi*^ and *hmg-4*^*RNAi*^ animals, motifs matching binding preferences for GATA TFs are enriched at closing sites ([Figures 4](#fig4){ref-type="fig"}B, 4C, and [S4](#mmc1){ref-type="supplementary-material"}L). Interestingly, the GATA TFs ELT-2 and ELT-7 are the master regulators of the intestinal fate ([@bib88]), and these closing sites are indeed highly enriched for ELT-2 binding based on available ChIP-seq data ([@bib52]) with a −log~10~ p value of 233.02 (*spt-16*^*RNAi*^) and 32.87 (*hmg-4*^*RNAi*^). Furthermore, a common TF-binding motif at opening chromatin sites matches that for JUN-1. Based on published ChIP-seq data ([@bib52]), JUN-1 binding is enriched in *spt-16*^*RNAi*^ opening ATAC-seq peaks with a −log~10~ p value of 1.33 ([Figures 4](#fig4){ref-type="fig"}B, 4C, and [S4](#mmc1){ref-type="supplementary-material"}M). Interestingly, the *C. elegans* bZIP TF JUN-1 is orthologous to the AP-1 subunit JUN and supports transcriptional reprogramming in the intestine upon fasting ([@bib94]).

Decreased binding accessibility for ELT-2/7 TFs that are required for intestinal gene expression might reflect a loss of intestinal cell fate maintenance upon RNAi against *hmg-4* or *spt-16*. Concomitantly, increased binding accessibility for JUN-1 might poise for gene expression changes in the intestine.

FACT Maintains the Intestinal and Germline Fate and Prevents Induction of Neuronal Genes by Antagonizing JUN-1 {#sec2.7}
--------------------------------------------------------------------------------------------------------------

To test the physiological relevance of predicted changes in chromatin accessibility for different TFs *in vivo*, we performed RNAi against *hmg-4* or *spt-16* and examined the expression of intestinal genes with four different reporters ([Figures 4](#fig4){ref-type="fig"}D and 4E) and immunostained for ELT-2 TF and the gut-specific intermediate filament protein IFB-2 ([Figure 4](#fig4){ref-type="fig"}F). Both *hmg-4* and *spt-16* RNAi depleted intestinal gene expression ([Figures 4](#fig4){ref-type="fig"}D--4F), suggesting that gut fate maintenance is impaired upon loss of FACT. To test whether FACT antagonizes factors that promote gene expression changes ([Figure 5](#fig5){ref-type="fig"}D), we tested whether JUN-1 is required for gut reprogramming because *hmg-4*/*spt-16* RNAi caused increased chromatin accessibility for JUN-1 binding sites. We found that the *jun-1* (*gk557*) mutant background significantly decreases neuronal gene induction upon *che-1*^*oe*^ in *hmg-4*^*RNAi*^ and *spt-16*^*RNAi*^ animals as compared to controls ([Figure 4](#fig4){ref-type="fig"}G), suggesting that JUN-1 promotes transcriptional reprogramming in the intestine upon FACT depletion ([Figures 4](#fig4){ref-type="fig"}G and 4H).Figure 5FACT Depletion Increases Efficiency of Reprogramming Human Fibroblasts(A) Reprogramming with human secondary fibroblasts carrying a doxycycline (DOX)-inducible OCT4/SOX2/KLF4/c-MYC (OSKM) cassette ([@bib18]) that were transfected with siRNAs against human SSRP1 or SUPTH16 before DOX induction.(B) Alkaline phosphatase (AP) staining of stem cell colonies 21 days after DOX treatment. Control experiment is scrambled siRNA (see [STAR Methods](#sec4){ref-type="sec"}).(C) Quantification of iPSC colonies (6 replicates) based on SSEA4 immunostaining for each knockdown condition. Paired Student's t test was used for statistical comparison, ^∗^p \< 0.05, ^∗∗∗^ p \< 0.001. Error bars represent SD.(D) Histological characterization of teratomas derived from grafting SSRP1 or SUPT16H depletion-derived iPSCs in mice. Teratomas reached 1.5 cm^2^ in size after 51--70 days and showed tissues of all three germ layers (ectoderm, endoderm, mesoderm). Scale bars represent 50 μm.(E) Forced expression of Ascl1, Brn2, and Mytl1 in human fibroblasts (Normal Human Dermal Fibroblats = NHDF cells) and SSRP1 or SUPT16H depletion enhances reprogramming of fibroblasts to neurons. One-way ANOVA test was used for statistical comparison, ^∗∗^ p \< 0.01. Error bars represent SEM.See also [Figure S5](#mmc1){ref-type="supplementary-material"}.

Next, we asked whether FACT plays a similar role in germline fate maintenance. Similar to the observed loss of intestinal gene expression upon *hmg-4* and *spt-16* RNAi, *hmg-3* RNAi caused loss of germline fate markers. Levels of germline P granules, as well as expression of the germline-specific *pie-1* reporter, significantly decreased ([Figures 4](#fig4){ref-type="fig"}I and 4J), indicating that FACT is required to maintain the germline fate ([Figure 4](#fig4){ref-type="fig"}K).

FACT Is a Reprogramming Barrier in Human Fibroblasts {#sec2.8}
----------------------------------------------------

As a chromatin regulator FACT is highly conserved, suggesting that its role in reprogramming may also be conserved. We tested whether FACT depletion in human fibroblasts enhances reprogramming using an hiF-T cell line that shows reprogramming to iPSCs with very low efficiency ([@bib18]). The hiF-T cells allow doxycycline (DOX)-inducible expression of OCT4, SOX2, KLF4, and C-MYC (OSKM) derived from a stable transgene ensuring comparable OSKM levels in repeat experiments ([@bib18]) ([Figure 5](#fig5){ref-type="fig"}A). The human FACT subunits SSRP1 and SUPT16H were depleted using small interfering RNA (siRNA) transfections for up to 4 days while transcript levels started recovering after 7 days ([Figure S5](#mmc1){ref-type="supplementary-material"}A). OSKM induction 48 hr after FACT knockdown considerably increased the numbers of iPSC colonies---around 2-fold upon SUPTH16 depletion ([Figures 5](#fig5){ref-type="fig"}B and 5C). FACT depletion does not increase OSKM expression ([Figure S5](#mmc1){ref-type="supplementary-material"}B), excluding the possibility of reprogramming enhancement due to the OSKM cassette being affected. These colonies show strong expression of several pluripotency markers, including NANOG, SSEA4 (Stage-specific embryonic antigen 4), and Tra-1-60 ([@bib69]) ([Figures S5](#mmc1){ref-type="supplementary-material"}C and S5D). Pluripotency was also confirmed in a physiological context by transplanting iPSCs into mice, which then formed teratomas containing tissues from all three germ layers ([@bib13], [@bib39], [@bib51]) ([Figure 5](#fig5){ref-type="fig"}D). Next, we asked whether FACT depletion in human fibroblast also enhances lineage reprogramming to neurons ([Figure 5](#fig5){ref-type="fig"}E). Our results suggest that FACT knockdown and forced expression of Ascl1, Brn2, and Mytl1 TFs that were previously shown to induce conversion of fibroblasts into neurons ([@bib95]) increased the conversion up to 1.5-fold compared to the control ([Figure 5](#fig5){ref-type="fig"}E), although transduction efficiency was relatively low (15%). Interestingly, beta-III tubulin-positive neurons derived from FACT-depleted fibroblasts show a higher degree of projection complexity than control cells ([Figure 5](#fig5){ref-type="fig"}E), indicating that the reprogrammed cells are generated earlier or mature faster. Taken together, FACT depletion in human fibroblasts enhances reprogramming to iPSCs and neurons, demonstrating that FACT's role as a safeguard of cellular identities is conserved in human cells.

FACT Depletion Directly and Indirectly Primes the Transcriptome for Pluripotency {#sec2.9}
--------------------------------------------------------------------------------

To understand how FACT functions to enhance human fibroblast reprogramming, we performed ChIP-seq for SSRP1 and SUPT16H, as well as ATAC-seq and RNA-seq upon FACT knockdown ([Figure 6](#fig6){ref-type="fig"}A). We found that FACT is largely enriched around annotated transcription start sites (TSS) ([Figure S6](#mmc1){ref-type="supplementary-material"}A). SSRP1 and SUPT16H show a high degree of correlation for promoter proximal ChIP-seq signal, gene expression changes upon knockdown, and altered accessibility within ATAC-seq peaks significantly changing (FDR 0.01) upon knockdown ([Figures 6](#fig6){ref-type="fig"}B and 6D), suggesting that, indeed, the two factors function together. FACT knockdown results in similar numbers of genes with increased (n = 2,447) and decreased (n = 2,183) expression ([Figure 6](#fig6){ref-type="fig"}C, FDR 0.1), as well as similar numbers of opening (n = 7,841) and closing (n = 8,117) transposase accessible regions ([Figure 6](#fig6){ref-type="fig"}D, FDR 0.01). Higher FACT ChIP-seq level for genes with significant promoter signal (FDR 0.1) does not translate to high or low expression levels ([Figures 6](#fig6){ref-type="fig"}E and [S6](#mmc1){ref-type="supplementary-material"}B) or expression changes (up or down) upon FACT knockdown ([Figures 6](#fig6){ref-type="fig"}F and [S6](#mmc1){ref-type="supplementary-material"}C). To further probe the relationship between FACT with chromatin structure and gene expression, we defined two classes of genes based on levels of promoter FACT ChIP-seq signal (see [STAR Methods](#sec4){ref-type="sec"}; [Figures 6](#fig6){ref-type="fig"}G and [S6](#mmc1){ref-type="supplementary-material"}D). Genes with insignificant FACT levels and detected in the RNA-seq (FACT low; adjusted p value \> 0.1) show a slightly lower expression level distribution than genes with significant FACT and detected in the RNA-seq (FACT high; adjusted p value \< 0.1) ([Figure S6](#mmc1){ref-type="supplementary-material"}E), yet the distributions of expression changes upon FACT knockdown were highly similar for both groups ([Figure 6](#fig6){ref-type="fig"}H and [Table S6](#mmc1){ref-type="supplementary-material"}). Similarly, while the levels of overall promoter-region ATAC-seq counts were slightly lower for the FACT low group ([Figure S6](#mmc1){ref-type="supplementary-material"}F), no obvious changes were seen in the distribution of promoter ATAC-seq fragment lengths (a measure of nucleosome positioning \[[@bib14]\]) ([Figure 6](#fig6){ref-type="fig"}I), nor were there drastic, uniform changes in mean positional patterns of ATAC-seq signal around annotated TSS for either group upon FACT knockdown ([Figure 6](#fig6){ref-type="fig"}J). Together, these observations suggest that FACT influences gene expression both positively and negatively and its presence or absence does not drastically alter chromatin accessibility genome wide. Interestingly, genes with high promoter FACT tend to be shorter than those with low promoter FACT ([Figure S6](#mmc1){ref-type="supplementary-material"}G), which is consistent with similar observations for HMG-3 in worms ([Figures S3](#mmc1){ref-type="supplementary-material"} and [S4](#mmc1){ref-type="supplementary-material"}).Figure 6FACT Depletion Directly and Indirectly Primes the Transcriptome for Pluripotency(A) Human fibroblasts were used for ChIP-seq analysis or transfected with siRNAs against human FACT subunits and used for ATAC-seq and RNA-seq analysis 48 hr after knockdown without OSKM induction.(B) Correlation of SSRP1 and SUPT16H log~2~-ChIP versus input ratios for TSS windows classified as high for at least one of the two FACT components (see [STAR Methods](#sec4){ref-type="sec"}). Density scale reflects number of TSS windows plotted per hexbin. The Spearman correlation Rho value is given.(C) Correlation of SSRP1 and SUPT16H knockdown RNA-seq log~2~-fold changes for genes that were significantly changed in at least one of the conditions (see [STAR Methods](#sec4){ref-type="sec"}; FDR 0.1). Density scale reflects number of genes plotted per hexbin. The Spearman correlation Rho value is given.(D) Hexbin density scatterplot of SUPT16H knockdown normalized ATAC-seq log~2~-fold changes plotted against SSRP1 knockdown normalized ATAC-seq log~2~-fold changes for ATAC-seq peaks that were significantly differential (FDR 0.01) in at least one of the conditions. Scale shows number of ATAC-seq peaks plotted per hexbin. The Spearman correlation Rho value is given.(E) Log~2~ ratio of SUPT16H ChIP versus Input plotted against Fragments Per Kilobase of transcript per Million mapped reads (FPKM) expression values from control RNA-seq for genes classified as FACT high and detected in the RNA-seq. Density scatterplot scale shows number of genes plotted per hexbin.(F) Log~2~-fold changes in expression levels from RNA-seq after SUPT16H knockdown plotted against log~2~ ratio of SUPT16H ChIP versus Input for genes classified as FACT high and detected in the RNA-seq. Density scatterplot scale shows number of genes plotted per hexbin.(G) Average positional profiles and heatmaps of library- and input-normalized SUPT16H ChIP-seq signal for genes whose TSS windows classified as FACT high or FACT low (see [STAR Methods](#sec4){ref-type="sec"}).(H) Violin plots of RNA-seq log~2~-fold change distributions following FACT knockdown for genes classified as being FACT high or FACT low. Red jitter dots reflect genes whose expression changed significantly upon FACT knockdown (FDR \< 0.1).(I) Density distributions of control or FACT-knockdown ATAC-seq fragment lengths intersecting TSS windows for genes classified as FACT high or FACT low.(J) Mean positional profiles and heatmaps of control or FACT-knockdown ATAC-seq signal for genes classified as FACT high or FACT low.(K) −Log~10~ enrichment p values of genes assigned ATAC-seq peaks changing, left, or genes showing expression changes upon FACT-knockdown, right, intersecting with clusters of genes previously reported to display specific expression profile changes during OSKM-induced reprogramming ([@bib18]). I, early somatic; II, late somatic; III, metabolic processes; IV, late embryogenesis; V, early embryogenesis; VI, pre-implantation; VII, shared soma versus pluripotency; VIII, early pluripotency; IX, late pluripotency; X, neuro-ectoderm.(L) RNA-seq fold changes upon FACT-knockdown for key genes previously implicated in reprogramming or pluripotency. Stars reflect adjusted p values.(M) Browser shot of ATAC-seq signal and library-normalized RNA-seq signal upon SSRP1 (SS^RNAi^) or SUPT16H RNAi (SU^RNAi^), and FACT ChIP-seq signals for the *PRRX1* gene. ATAC-seq peaks and *RNA-seq* genes called as significantly changed are noted below the respective signal tracks.(N) *De novo*-generated motifs from ATAC-seq peaks differentially changing upon FACT-knockdown and TF family-representatives matching the given motif.(O and P) Browser shots as described in (M) for the (O) *CEBPB* and (P) *SALL4* genes.(Q) Zoomed-in browser shot of upstream enhancer-candidate for SALL4. Shown are control and FACT-knockdown signals for ATAC-seq and publicly available CEBPB ChIP-seq in human embryonic stem cells (ESCs). Two CEBPB biding sites were found within the 387-bp accessible region by matching the consensus RTTKCAYMAY and allowing one mismatch.(R) Model for how FACT depletion primes for reprogramming: direct changes in gene expression for TFs such as CEBPB lead to promoter distal, indirect chromatin accessibility changes at genomic loci of key regulators such as SALL4.See also [Figure S6](#mmc1){ref-type="supplementary-material"} and [Tables S5](#mmc6){ref-type="supplementary-material"} and [S6](#mmc1){ref-type="supplementary-material"}.

FACT Depletion Increases Expression of Pluripotency-Promoting Factors while Decreasing Expression of Reprogramming-Inhibitors {#sec2.10}
-----------------------------------------------------------------------------------------------------------------------------

To connect FACT to the observed reprogramming phenotype, we intersected our genome-wide datasets with gene clusters previously defined for their behavior over a reprogramming time course following induction of OSKM ([@bib18]). Genes with decreased expression or assigned ATAC-seq peaks that change upon FACT knockdown are significantly enriched in somatic clusters that display decreased expression upon OSKM induction ([Figure 6](#fig6){ref-type="fig"}K, clusters I and II). Furthermore, genes whose expression increases upon FACT knockdown are enriched in pluripotency clusters that have increased expression upon OSKM induction ([Figure 6](#fig6){ref-type="fig"}K, clusters VIII and X). Expression changes for several genes known to positively and negatively influence pluripotency ([Figure 6](#fig6){ref-type="fig"}L) provide strong molecular support for increased reprogramming efficiency upon FACT knockdown. For instance, FACT depletion leads to decreased expression of previously described reprogramming inhibitors such as the histone chaperone CAF1 subunits CHAF1B and RBBP7 ([@bib19]), repressive chromatin regulators including SUV39H1/2 and NR2F1 ([@bib64]), PRRX1 ([@bib73], [@bib97]), the phosphatase PTPN11 ([@bib75]), as well as SUMO2 ([@bib11]) ([Figure 6](#fig6){ref-type="fig"}L). Concomitantly, FACT depletion increases expression of reprogramming-promoting factors such as ESRRB, LIN28, and SALL4 ([@bib17]), JMJD2C ([@bib90]), CEBPB ([@bib23]), FGF2 ([@bib44]), and BMP2 ([@bib21], [@bib83]) ([Figure 6](#fig6){ref-type="fig"}L). Visually inspecting these key reprogramming-associated genes ([Figures 6](#fig6){ref-type="fig"}M--6P and [S6](#mmc1){ref-type="supplementary-material"}L) suggested that changes in gene expression upon FACT knockdown are likely to be a combination of direct effects on genes with substantial FACT occupancy and indirect effects through distal binding of TFs whose expression themselves changes. Indeed, 95% of ATAC-seq peaks that change upon FACT knockdown are distal to annotated TSS, and these changed regions were similarly assigned to FACT ChIP-seq high or low genes ([Table S6](#mmc1){ref-type="supplementary-material"}).

FACT Depletion Increases Chromatin Accessibility for CEBP Family TFs at the Enhancer Region of the Reprogramming-Promoting Factor SALL4 {#sec2.11}
---------------------------------------------------------------------------------------------------------------------------------------

To find candidates of distal-binding regulators, we performed *de novo* motif generation on sequences from distally annotating ATAC-seq peaks either opening or closing upon FACT depletion. A highly enriched motif at closing chromatin sites matches that for the Runt-related TF 1 (RUNX1) ([Figures 6](#fig6){ref-type="fig"}N and [S6](#mmc1){ref-type="supplementary-material"}I). Interestingly, RUNX1 depletion has been shown to enhance reprogramming ([@bib23]), suggesting that decreased chromatin accessibility for RUNX1 binding sites upon FACT depletion could have analogous effects. Likewise, decreased accessibility for sequences matching the TEAD family TF motif ([Figures 6](#fig6){ref-type="fig"}N and [S6](#mmc1){ref-type="supplementary-material"}I) could affect the TEAD/HIPPO pathway, another previously reported reprogramming barrier ([@bib74]). Interestingly, motifs matching the CEBP family of TFs, which can enhance Mouse Embryonic Fibroblast (MEF) reprogramming ([@bib23], [@bib24]), are enriched in ATAC-seq peaks opening upon FACT depletion. The *CEBPB* gene itself is highly occupied by FACT and up-regulated upon FACT depletion, yet has no obviously changing regulatory regions, and is therefore a candidate for direct regulation by FACT ([Figure 6](#fig6){ref-type="fig"}O). Meanwhile, the *SALL4* gene, which has been strongly implicated in pluripotency ([@bib17], [@bib68], [@bib98]), also shows high FACT occupancy and increased expression upon FACT knockdown ([Figure 6](#fig6){ref-type="fig"}P), yet a strong enhancer candidate ∼9 kb upstream of the SALL4 TSS is clearly opening upon FACT depletion and has two binding sites matching the CEBP TF family within a 387-bp sequence ([Figure 6](#fig6){ref-type="fig"}Q). Overall, we see a clear enrichment between genes showing reduced expression and genes having distal regulatory regions that close upon FACT knockdown, as well as between genes showing increased expression and genes having distal regulatory regions that open upon FACT knockdown, but not vice versa ([Figure S6](#mmc1){ref-type="supplementary-material"}K). This leads us to propose a model where FACT safeguards somatic gene programs via proper control (both positive and negative) of transcriptional regulators and hinders the pluripotent state. Disruption of FACT leads to mis-regulation of such factors and, consequently, to indirect changes in the distal regulome, as exemplified by our mini CEBPB-SALL4 network ([Figure 6](#fig6){ref-type="fig"}R).

Discussion {#sec3}
==========

The identification of FACT as a barrier for cell conversion supports a recent notion by Alvarado and Yamanaka ([@bib2]) that cell fate maintenance factors have not been widely explored but might provide new avenues for reprogramming. Overall, the discovery of FACT as a reprogramming barrier was unexpected since FACT is predominantly known as a positive regulator of gene expression ([@bib66]) (reviewed by [@bib37], [@bib78]). It is anticipated that loss of FACT has both consequences: repression of genes that require FACT activity and increased gene expression due to indirect effects as a consequence of diminished factors that act as repressors. However, it is surprising that genes, such as *CEBPB* in fibroblasts, which are directly bound by FACT, show increased expression upon FACT depletion, suggesting a repressive function for FACT. While the increased accessibility of the SALL4 enhancer for CEBP binding illustrates a combined mode of direct and indirect effects that result in increased gene expression, it remains to be determined how chromatin sites, such as the SALL4 enhancer, become more accessible upon FACT depletion. Since 95% of changing chromatin sites in human cells are distal to annotated TSS, it is conceivable that TFs encoded by genes that change expression directly upon FACT depletion are apt to alter chromatin at distal enhancer sites. Also, loss of FACT might lead to more accessible chromatin due to persistence of nucleosome-depleted sites since FACT re-establishes the nucleosome signature after RNA polymerase II passage ([@bib7], [@bib43]). Additionally, decreased gene expression upon FACT depletion might obliterate the insulation of active and repressed chromatin regions as previously implied for cell identity genes ([@bib27]).

Overall, the preponderance of effects that favor cell fate conversion, such as decreased expression of reprogramming inhibitors and increased levels of promoting factors, might result in the observed reprogramming enhancement. This is specifically reflected by our finding that expression of SALL4 ([@bib17], [@bib68], [@bib98]) together with the TFs ESRRB and LIN28B, which are all members of the deterministic pluripotency circuitry ([@bib16]), are increased upon FACT depletion. Generally, we speculate that depletion of global gene expression regulators such as FACT, or other previously identified reprogramming barriers including LIN-53, CAF-1, or SUMO2 ([@bib11], [@bib20], [@bib93]), lead to a disordered gene expression program of the host cell. This "gene expression chaos" is the window of opportunity for ectopically expressed TFs to re-establish a new ordered gene expression program resulting in cell identity conversion. While this proposed concept suggests a more generic permissiveness for reprogramming, further investigation will be required to determine the range of different target cell fates that can be generated by reprogramming upon FACT depletion. For application aspects, transient FACT depletion in human cells is sufficient to enhance reprogramming, thereby providing new avenues for clinical approaches. It has been shown that short-term OSKM expression is sufficient for *in vivo* reprogramming in mice, thereby preventing formation of tumors ([@bib105]). In general, the combination of transient depletion of reprogramming barriers and short-term forced-expression of TFs will have fewer deleterious effects while ensuring efficient reprogramming.

Loss of FACT in *C. elegans* leads to reduced maintenance of the intestinal and germ cell fates. Strikingly, motifs for JUN-1 are enriched in both human fibroblasts and *C. elegans* at opening chromatin sites upon FACT depletion, indicating a remarkable conservation of gene regulation networks. Increased permissiveness for JUN-1 activity could promote changes in cell identities in *C. elegans*, which is in line with a previous study showing that JUN-1 promotes transcriptional reprogramming in the intestine together with the FOXO TF DAF-16 upon starvation ([@bib94]). It is therefore conceivable that high levels of overexpressed CHE-1 co-opts JUN-1 to reprogram intestinal gene expression upon FACT depletion. Our observation that FACT depletion in *C. elegans* appears to allow mainly reprogramming to neurons needs to be interpreted with caution. Specifically, the transgenes to overexpress the intestine or muscle fate TFs ELT-7 or HLH-1, respectively, might suffer from germline-mediated silencing, which is a well-known phenomenon in *C. elegans* ([@bib48]). Furthermore, expression of ELT-7 and its downstream factor ELT-2 are suppressed upon FACT depletion. Hence, it is plausible that FACT depletion causes a rather unfavorable context for TFs such as ELT-7 to induce the intestinal fate in other tissues.

Generally, FACT's combined role in maintaining gene expression and preventing chromatin binding accessibility for TFs such as CEBPB or Jun/JUN-1 in human fibroblasts and *C. elegans* seems conserved and might be essential to prevent deviant expression of genes belonging to other cell identities in both species. Seen in a broader context, FACT being an impediment for converting cell fates in *C. elegans* and human cells exemplifies that reprogramming barriers are evolutionarily conserved. This phenomenon is also reflected by the previously identified barrier for germ cell reprogramming LIN-53 in *C. elegans* (CAF-1p48/RBBP7 in mammals) ([@bib93]) and the LIN-53-containing histone chaperone CAF-1, which is a barrier during reprogramming of mouse fibroblasts ([@bib20]). Such evolutionary conservation is likely in metazoan organisms, which need to prevent the induction of ectopic gene expression programs. Challenges including global signaling events during development and tissue regeneration (e.g., wound healing), environmental stress, as well as aging could initiate ectopic gene expression profiles, resulting in cellular transformations if safeguarding mechanisms are not in place. In this context, our study demonstrates the versatility of *C. elegans* to serve as a powerful gene discovery tool for identifying unanticipated reprogramming barriers.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**anti-SPT-16 rabbit polyclonal peptide antibodyThis paperN/Aanti-HA mono mouse antibody (12CA5)RocheCat\#11583816001ELT-2 mono mouse antibodyDevelopmental Studies Hybridoma BankCat\#455-2A4P-Granule mono mouse antibodyDevelopmental Studies Hybridoma BankCat\#OIC1D4intermediate filament subunit mono mouse antibodyDevelopmental Studies Hybridoma BankCat\#MH33SSEA-4, DyLight 488 conjugate mono mouse antibodyThermo ScientificCat\#MA1-021-D488\
RRID: [AB_2536688](nif-antibody:AB_2536688){#intref0010}NANOG rabbit polyclonal antibodyThermo ScientificCat\#PA1-097\
RRID: [AB_2539867](nif-antibody:AB_2539867){#intref0015}Anti-Beta III Tubulin AntibodySigma-AldrichCat\#AB9354Go-ChIP-Grade Purified anti-SSRP1 AntibodyBioLegendCat\#609709\
RRID: [AB_2650946](nif-antibody:AB_2650946){#intref0020}SPT16 (D7I2K) Rabbit mAbCell SignalingCat\#12191Anti-HA tag antibody - ChIP GradeAbcamCat\#ab9110\
RRID: [AB_307019](nif-antibody:AB_307019){#intref0025}**Bacterial and Virus Strains**Escherichia coli, OP50CAENORHABDITIS GENETICS CENTER (CGC)WormBase ID: OP50Escherichia coli: HT115(DE3)CAENORHABDITIS GENETICS CENTER (CGC)WormBase ID: HT115(DE3)C. elegans total RNAi Collection (Ahringer)Source BioscienceCat\#3318_Cel_RNAi_completeC. elegans supplemental RNAi Collection (Ahringer)Source BioscienceCat\#3317_Cel_RNAi_supplement_wholeRTTA, tetO-Ascl1, tetO-Brn2 and tetO-Myt1l (BAM)[@bib95]N/A**Chemicals, Peptides, and Recombinant Proteins**Y-27632 2HCl ROCK1 inhibitorBiozol DiagnosticaCat\#SEL-S1049-10MM**Critical Commercial Assays**Pluripotent Stem Cell 4-Marker Immunocytochemistry KitThermo FisherCat\#A24881Alkaline Phosphatase Staining Kit IIStemgentCat\#00-0055Nextera DNA Library Preparation KitIlluminaCat\#FC-121-1030TruSeq RNA Library Prep Kit v2IlluminaCat\#RS-122-2001NEXTflex Rapid Directional qRNA-Seq KitBioo ScientificCat\#NOVA-5130-02DRibo-Zero Gold rRNA Removal Kit (H/M/R)IlluminaCat\#MRZG12324iDeal ChIP-seq Kit for Transcription FactorsDaigenodeCat\#C01010055NEXTflex qRNA-Seq Kit v2Bioo ScientificCat\#NOVA-5130-12NextSeq 500/550 High Output v2 kit, 150 cyclesIlluminaCat\#FC-404-2002**Deposited Data**Raw and analyzed dataThis paperGEO: [GSE98758](ncbi-geo:GSE98758){#intref0030}Human CEBP ChIP-seqENCODEENCFF377MTQ.bamHuman H2AFZ ChIP-seqENCODEENCFF255USS.bigWigHuman H3K27ac ChIP-seqENCODEENCFF858MGD.bigWigHuman H3K4me3 ChIP-seqENCODEENCFF837XME.bigWigWorm ChIP-seq b0310.2_embryomodENCODE/modERNENCFF230GNZ.bedWorm ChIP-seq elt-1_l3modENCODE/modERNENCFF217KEA.bedWorm ChIP-seq elt-2_l3modENCODE/modERNENCFF707HUO.bedWorm ChIP-seq fkh-6_embryomodENCODE/modERNENCFF671ZAU.bedWorm ChIP-seq jun-1_l4modENCODE/modERNspp.optimal.JUN-1_OP234_WA_L4_IP_Rep0.tagAlign_VS_JUN-1_OP234_WA_L4_Input_Rep0.tagAlign.regionPeakWorm ChIP-seq pha-4_l4modENCODE/modERNENCFF209ONL.bedWorm ChIP-seq skn-1_l4modENCODE/modERNENCFF798LMX.bedWorm ChIP-seq unc-55_l2modENCODE/modERNENCFF346FAK.bedWorm ChIP-seq ztf-16_embryomodENCODE/modERNENCFF341MDZ.bed**Experimental Models: Cell Lines**Mouse: CF-1 MEF 2M Mito-CTebu-BioCat\#222GSC-6201MHuman: polycistronic human OCT4/KLF4/c-MYC/SOX2 (OKMS) cassette (hiF-Tcells)[@bib18]\
Laboratory of Dr. MikkelsenN/AHuman: Human Dermal Fibroblasts (NHDF)LonzaCat\#CC-2511**Experimental Models: Organisms/Strains**N2 *C. elegans* wild isolateCaenorhabditis Genetics CenterWormBase ID: N2JR3373 *wIs125\[hsp-16-2::elt-7 hsp-16-41::elt-7\]; rrIs1 \[elt-2::GFP + unc-119(+)\]*Laboratory of Dr. Joel RothmanWormBase ID: JR3373LW697 *ccIs4810\[pJKL380.4; lmn-1p::lmn-1::GFP::lmn-1 3\'utr + pMH86; dpy-20(+)\] I*.Caenorhabditis Genetics CenterWormBase ID: LW697OD56 *ltIs 37\[pie-1p::mCherry::his-58 unc-119(+)\];unc-119(ed3) III*.Caenorhabditis Genetics CenterWormBase ID: OD56SS104  *glp-4(bn2) I*.Caenorhabditis Genetics CenterWormBase ID: SS104NL2507 *pkIs1582\[let-858::GFP + rol-6(su1006)\]*Caenorhabditis Genetics CenterWormBase ID: NL2507BAT28/OH9846 *otIs305 \[hsp-16.48prom::che-1::3XHA::BLRP; rol-6(su1006)\]; ntIs1 \[gcy-5::gfp; lin-15b(+)\] V*.Caenorhabditis Genetics CenterWormBase ID: OH9846BAT012 *barIs12\[elt-2prom::gfp; myo-3p::NmBirAo\]*This paperN/ABAT026 *otIs284 \[hsp-16.48prom::che-1::3XHA::BLRP; rol-6(su1006)\]; ntIs1 \[gcy-5::gfp; lin-15b(+)\] V.; hdIs30 \[glr-1::dsRED\]*This paperN/ABAT032 *glp-1(ar202) III.; otIs305 \[hsp-16.48prom::che-1::3XHA::BLRP; rol-6(su1006)\]; ntIs1 \[gcy-5::gfp; lin-15b(+)\] V*.This paperN/ABAT044 *juIs244 \[ttr-39prom::mCherry, ttx-3prom::gfp\]; otIs305 \[hsp-16.48prom::che-1::3XHA::BLRP; rol-6(su1006)\]; ntIs1 \[gcy-5::gfp; lin-15b(+)\] V*.This paperN/ABAT046 *otIs133 \[ttx-3prom::mCherry\]; otIs284 \[hsp-16.48prom::che-1::3XHA::BLRP; rol-6(su1006)\]; ntIs1 \[gcy-5::gfp; lin-15b(+)\] V.; hdIs30 \[glr-1::dsRED\]*This paperN/ABAT068 *otEX4945 \[hs:hlh-1, rol-6(su1006)\]; mgIs25 \[unc-97prom::gfp\]*This paperN/ABAT109 *otIs305 \[hsp-16.48prom::che-1::3XHA::BLRP; rol-6(su1006)\] V*.This paperN/ABAT139 *stIs10086 \[ges-1::H1-Wcherry + unc-119(+)\]*This paperN/ABAT160 *itIs37 \[pie-1p::mCherry::his-58(pAA64), unc-119(+)\]; otIs305 \[hsp-16.48prom::che-1::3XHA::BLRP; rol-6(su1006)\] ntIs1 \[gcy-5p::GFP, lin-15(+)\] V*.This paperN/ABAT282 *barIs40 \[vit-5::2xNLS::TagRFP\]*This paperN/ABAT284 *stIs10131 \[elt-7::H1-wCherry + unc-119(+)\]*This paperN/ABAT287 *ntIs1 \[gcy-5::gfp; lin-15b(+)\] V*.This paperN/ABAT326 *otIs263 \[ceh-36prom::tagRFP\]; otIs305 \[hsp-16.48prom::che-1::3XHA::BLRP; rol-6(su1006)\]; ntIs1 \[gcy-5::gfp; lin-15b(+)\] V*.This paperN/ABAT453 *barEx147 \[hsp-16.4prom::unc-30; hsp-16.2prom::unc-30; rol-6(su1006)\]; juIs244 \[ttr-39prom::mCherry, ttx-3prom::gfp\]*This paperN/ABAT522 *otis393 \[ift-20prom::NLS::tagRFP\]; otIs305 \[hsp-16.48prom::che-1::3XHA::BLRP; rol-6(su1006)\]; ntIs1 \[gcy-5::gfp; lin-15b(+)\] V*.This paperN/ABAT525 *hmg-3 (tm2539) / dpy-5(e61) unc-13(e1091) I*.This paperN/ABAT527 *otIs355 \[rab-3prom::NLS::TagRFP\]; otIs305 \[hsp-16.48prom::che-1::3XHA::BLRP; rol-6(su1006)\]; ntIs1 \[gcy-5::gfp; lin-15b(+)\] V*.This paperN/ABAT606 *edIs6 \[unc-119::gfp + pRF4\[rol-6(su1006)\]\] IV.; otIs305 \[hsp-16.48prom::che-1::3XHA::BLRP; rol-6(su1006)\] V*.This paperN/ABAT1560 *hmg-3(bar24\[hmg-3::3xHA\]) I. protein tag CRISPR engineered*This paperN/ABAT1753 *hmg-3(bar24\[hmg-3::3xHA\]) I. 2x outcrossed*This paperN/ABAT1945 *jun-1(gk557) II; otIs305\[hsp::che-1::3xHA, rol-6\] ntIs1\[gcy-5::GFP\]*This paperN/ABAT1967 *hmg-4(bar32\[hmg-4::3xHA\]) III. protein tag CRISPR engineered*This paperN/A**Oligonucleotides***hmg-3(bar24)* generation: *hmg-3 sgRNA F*\
TCTTatccgattcaccagaagact\
*hmg-3 sgRNA R*\
AAACagtcttctggtgaatcggat *hmg-3::3xHA F1*\
cgatgagccgctaaaggcgaagaaagacgaatccgatgct\
gcttctgagtcttctggtgaatcggatTACCCATACGA\
CGTTCCAGA\
*hmg-3::3xHA R1*\
gtaagaaggaaggcgaataaaaagcaacaataaaatatttag\
tcagaaaaTTAAGCGTAATCTGGGACGTCA\
*hmg-3::3xHA F2*\
cgatgagccgctaaaggc\
*hmg-3::3xHA R2*\
gtaagaaggaaggcgaataaaaagc\
*hmg-3::3xHA Fs*\
gatacggatgattccgatgacg\
*hmg-3::3xHA Rs*\
gaaggaaggcgaataaaaagcaacThis paperN/A*dpy-10(cn64) sgRNA F*\
TCTTgctaccataggcaccacgag\
*dpy-10(cn64) sgRNA R*\
AAACctcgtggtgcctatggtagc\
*dpy-10(cn64) ssODN*\
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ACGTCCCAGATTACGCTTAAATTATTAATTTTGTTTC\
TTTTAAACTCGTGTACTATC *hmg-4::3xHA F*\
gattcggacgatgaggagc\
*hmg-4::3xHA R*\
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Contact for Reagent and Resource Sharing {#sec4.2}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Baris Tursun (<baris.tursun@mdc-berlin.de>).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### *C. elegans* Strains Used in the Study {#sec4.3.1}

Information on strains including genotypes are provided in [Table S7](#mmc1){ref-type="supplementary-material"}. Hermaphrodites were used for phenotype scoring such as reprogramming effects, smFISH, reporter assays, and immunohistochemistry.

### Nematode Culture {#sec4.3.2}

*C. elegans* strains were maintained using standard condition on OP50 bacteria at 20°C ([@bib12]). All heat-shock and temperature-sensitive strains were kept at 15°C (See [Table S7](#mmc1){ref-type="supplementary-material"}).

### Cell Culture {#sec4.3.3}

Human secondary fibroblasts carrying a doxycycline (DOX)-inducible, polycistronic human OCT4/KLF4/c-MYC/SOX2 (OKMS) cassette (hiF-Tcells) ([@bib18]) were cultured in hiF medium (DMEM/F12 Gltuamax supplemented with 10% FBS, 1% NEAA, 0,1% beta-mercaptoethanol 100 U ml^−1^ penicillin, 100 μg ml^−1^ streptomycin and 16 ng/ml FGFbasic). hiF-T cells were passaged every 3 days, using a splitting ratio of 1:3 as described before ([@bib18]). For experiments, 80.000 hiF-T cells/ well of a 12-well plate treated with attachment factor were seeded and incubated overnight at 37°C. According to the previously published study ([@bib18]), hiF-T cells were derived from BJ human foreskin fibroblasts (male gender).

Normal Human Dermal Fibroblasts (NHDF) were obtained from the company Lonza and were used for direct reprogramming experiments as described below. According to the manufacturer NHDF are primary human neonatal dermal fibroblasts derived from neonatal foreskins (male gender). Cells were first grown in Fibroblast Growth Medium (FGM, Invitrogen) before transferring them to neuronal medium (DMEM/F2, Invitrogen), apotransferrin (100mg/ml), insulin (5mg/ml), sodium selenite (30 nM), progesterone (20 nM), putrescine (100 nM), penicillin/streptomycin) supplemented with neurotrophic factors) as described before ([@bib95]).

Method Details {#sec4.4}
--------------

### RNAi in *C. elegans* {#sec4.4.1}

For RNAi, worms were grown on plates seeded with RNAi bacteria from Ahringer library (Source Bioscience). RNAi against *Renilla luciferase* (Rluc) was used as control. Whole-genome RNAi screen was designed as an F1 screen using a standard RNAi feeding protocol ([@bib46]). RNAi bacteria for the screen were seeded on 6-well plates and the screen was carried out in duplicates. In total, 19791 genes on 6 chromosomes were screened. Reprogramming experiments were carried out either as P0 for *hmg-4* and *spt-16*, or F1 for *hmg-3* RNAi using a standard feeding protocol ([@bib47]). For P0 experiments, worms were synchronized by bleaching and L1 larvae were put on RNAi plates; for F1 RNAi, synchronized L1s were grown at 15°C on normal food until they reached L4 stage when they were transferred on RNAi plates. Worms on RNAi plates were grown at 15°C until most of the P0 or F1 progeny reached L4 stage. The plates were heat-shocked at 37°C for 30 min followed by an overnight incubation at 25°C ([@bib50], [@bib93]). RNAi in embryos against a number of genes causes lethality during early development which was also previously observed ([@bib47]). Therefore, we additionally performed RNAi only after birth of the animals for such RNAi targets. Plates were screened for presence of ectopic GFP the following day under a dissecting scope. To induce the Glp phenotype in *glp-1(ar202)*, the animals were shifted to room temperature 8 hrs before the heat-shock. It is important to note that F1 RNAi against *spt-16* caused embryonic lethality thereby not allowing to test for *gcy-5::gfp* induction in the germline as seen upon *hmg-3* F1 RNAi. For double RNAi, bacteria were grown as saturated culture. The OD600 was measured to ensure that the bacteria were mixed in an appropriate 1:1 ratio and subsequently seeded on RNAi 6-well plates. The library screened for suppression in *hmg-3*-depleted background and entire results are listed in [Table S4](#mmc5){ref-type="supplementary-material"}. For time course experiments, screening for the presence of ectopic GFP was done 0, 4, 8, 12, 24, 36 and 48 hrs after heats-hock. The *C. elegans* lines used in this study are listed and described in detail in [STAR Methods](#sec4){ref-type="sec"}.

### Generation of CRISPR Alleles {#sec4.4.2}

CRISPR engineering was performed by microinjection using a PCR repair template and the *dpy-10* co-CRISPR approach The injection mix contained a plasmid that drives expression of Cas9 (50ng/μl, a gift from John Calarco, Addgene \#46168), one that drives expression of *dpy-10(cn64)* sgRNA (50ng/μl), a *dpy-10(cn64)* PAGE-purified 99mer single-stranded oligodeoxynucleotide (ssODN) HR template (50ng/μL; IDT), a plasmid expressing the sgRNA targeting the *hmg-3* locus (dBT620, 50ng/μl) and a PCR repair template to introduce the *3xHA* knock-in at the 3' end of *hmg-3* (90ng/μl). To generate the sgRNA plasmids, annealed oligo pairs were ligated into BbsI-digested pJJR50 (a gift from Mike Boxem, Addgene\#75026). To generate the PCR repair template, 3xHA tag was flanked with approximately 50bp homology arms on both 3' and 5' side for insertion at the 3' end of the *hmg-3* or *hmg-4* locus. Screening for successful knock-in events was done by pooling several injectants on the same plate and picking off independent F1 animals to generate transgenic lines([@bib3]). Positive hits were homozygoused for the knock-in by singling and genotyping worms and the knock-in was confirmed by Sanger sequencing.

Sequences of the oligonucleotides used for the generation of *hmg-3(bar24)* and *hmg-4(bar32)* are reported in [STAR Methods](#sec4){ref-type="sec"}.

### Antibody Staining {#sec4.4.3}

For staining anti-SPT16 (rabbit polyclonal peptide antiboy, 1:200) antibodies, worms were resuspended 0,025 % glutaraldehyde and frozen using freeze-crack protocol ([@bib28]). Acetone/methanol fixation was used to prevent gonad extrusion. For anti-HA staining (anti-HA mono mouse antibody, Roche, at 1:1000 dilution) whole worms were fixed and permeabilized following a previously described method ([@bib8]). In brief, after washing, worms were resuspended in RFB (160 mM KCl; 40 mM NaCl; 20 mM EGTA; 10 mM Spermidine) + 2% formaldehyde followed by three freeze-thaw cycles. After incubation for 30 min at 25°C, the sample was washed with TTE (100 mM Tris pH 7,4; 1 % Triton; 1mM EDTA) and incubated for 4 h at 37°C with shaking in TTE + 1% beta-Mercaptoethanol. The sample was washed in BO3 buffer (10 mM H~3~BO~3~; 10 mM NaOH; 2 % Triton) and further incubated for 15 min at 37°C with shaking in BO3 buffer + 10 mM DTT. After another wash with BO3, BO3 buffer + 0,3 % H~2~O~2~ was added and incubated for 15 min at 25°C. The sample was washed once more with BO3, blocked with 0,2 % gelatin + 0,25 % Triton in PBS and stained. Primary antibodies were diluted in PBS with 0,25 % Triton + 0,2 % gelatin, added to the fixed worms and incubated overnight at 4°C. After washing in PBS + 0,25 % Triton, secondary antibodies (Alexa Fluor dyes at 1:1500 dilution) were applied and incubated overnight at 4°C. Samples were washed in PBS + 0,25 % Triton and mounted on glass slides with DAPI-containing mounting medium (Dianove, \#CR-3448). For anti-P granule, ant-ELT-2 and anti-IFB-2 staining (anti-OIC1D4-s - P-granules, anti-455-2A4-s (ELT-2), anti-MH33-s - intermediate filament mono mouse antibody, repectively, Hybridoma bank, at 1:150 dilution) worms were dissected and processed as described before ([@bib103]). In brief, worms were cut below the pharynx so that the gonads and intestines protrude, fixed for 15 min in 4% paraformaldehyde, followed by washing 3 times with PBS with 0,25 % Triton. Worms were then blocked for 1 hour in PBS with 0,25 % Triton + 0,2 % gelatin, followed by incubation with primary antibodies incubated overnight at 4°C. After washing in PBS + 0,25 % Triton, secondary antibodies (Alexa Fluor dyes at 1:1500 dilution) were applied and incubated overnight at 4°C. Samples were then washed in PBS + 0,25 % Triton and mounted on glass slides with DAPI-containing mounting medium as described above. The following antibodies were used: anti-OIC1D4-s (P-granules), anti-455-2A4-s (ELT-2), anti-MH33-s - intermediate filament (IFB-2), mono mouse antibodies, Hybridoma bank, at 1:150 dilution.

### Single Molecule Fluorescent *In Situ* Hybridization (smFISH) {#sec4.4.4}

smFISH was performed using Custom Stellaris FISH probes, purchased from Biosearch Technologies and the staining was done according to the manufacturer's protocol. Sequences of all the smFISH probes used are listed in [STAR Methods](#sec4){ref-type="sec"}.

### Cell-Cycle Arrest by HU Treatment {#sec4.4.5}

Hydroxyurea (HU) treatment was carried out as previously described ([@bib30], [@bib71], [@bib84]). In brief, HU was added to seeded RNAi plates at a final concentration of 250 μM. L4 worms grown on RNAi plates were transferred to HU plates and incubated at room temperature for 5 hrs prior to heat-shock in order to induce CHE-1 expression. After overnight incubation, worms were assessed for GFP induction in the germline as described above.

### siRNA Knockdown in Human Cells {#sec4.4.6}

hiF-T cells were cultured as described above and passaged every 3 days, using a splitting ratio of 1:3 as described before ([@bib18]). For siRNA experiments, 80.000 hiF-T cells/ well of a 12-well plate treated with attachment factor were seeded and incubated overnight at 37°C. siRNA knockdown was performed the following day by a reverse transfection method using DharmaFECT 1 and 40 nM siRNA pool reagents purchased from Dharmacon according to the manufacturer's instructions. Sequences of all the siRNA reagents used are described in [Table S8](#mmc1){ref-type="supplementary-material"}. To monitor knockdown efficiency, RNA was isolated using Qiagen RNeasy Plus Mini Kit 24h, 48h, 72h or 7 days after siRNA transfection. To control for OSKM expression after SSRP1 and SUPT16H depletion, RNA was isolated from siRNA transfected cells 48h after knockdown without prior Doxycycline treatment. cDNA was synthesized with oligo dT primers using the GoScript Reverse Transcriptase (Promega). cDNA was used for qPCR with the Maxima SYBR Green qPCR Master Mix (2X) (Thermo Scientific) according to the manufacturer's instructions on an ABI PRISM 7700 system (Applied Biosystems). The real-time PCR data analysis was done by using comparative C~T~ method (2008). Gene expression levels were calibrated to the housekeeping gene GAPDH and normalized to Rluc. Sequences of qRT-PCR primers used are described in [STAR Methods](#sec4){ref-type="sec"}.

### Reprogramming Experiments with hiF-T Cells {#sec4.4.7}

Reprogramming experiments were performed by seeding hiF-T cells on irradiated mouse embryonic fibroblasts (MEF, GlobalStem) 24 h after siRNA transfection. Induction of OSKM by DOX supplementation (2μg/ml) was started the next day in hiF medium for the first 2 days and then in KSR medium (DMEM/F12 Gltuamax supplemented with 20% KSR, 1% NEAA, 0,1% beta-mercaptoethanol 100 U ml^−1^ penicillin, 100 μg ml^−1^ streptomycin, 8 ng/ml FGFbasic and ROCK1 inhibitor (Y-27632-2HCl, Biozol Diagnostica, final concentration 1μM)) as described previously ([@bib18]).

### Reprogramming Experiments with NHDF Cells {#sec4.4.8}

Direct reprogramming experiments were performed by transducing Normal Human Dermal Fibroblasts (NHDF cells, Lonza) with RTTA, tetO-Ascl1, tetO-Brn2 and tetO-Myt1l (BAM) in a 1.2:1:1.5:2.5 ratio and supplemented with polybrene (c.f. 8 μg/ml) 24 h before siRNA transfection to deplete FACT. Induction of BAM by DOX supplementation (2 μg/ml) was started the next day in neuronal medium ((DMEM/F2 (Invitrogen), apotransferrin (100mg/ml), insulin (5mg/ml), sodium selenite (30 nM), progesterone (20 nM), putrescine (100 nM), penicillin/streptomycin) supplemented with neurotrophic factors) as described before ([@bib95]).

### Phenotypic Characterization of iPS Cells {#sec4.4.9}

iPSC colonies were characterized after ∼21 days of reprogramming. Alkaline phosphatase activity was measured using an enzymatic assay for alkaline phosphatase (Alkaline Phosphatase Staining Kit II, Stemgent) according to the manufacturer's instructions. Number of colonies formed in each condition was counted based on SSEA-4 positive colonies. Immunohistochemistry with SSEA-4 Antibody (DyLight 488 conjugate, Thermo Scientific) was performed according to the manufacturer's protocol at 1:500 dilution. Cells were fixed with 4%PFA in PBS and permeabilized with 0.1% Tween-PBS before antibody incubation. The pluripotency staining was performed using the Pluripotent Stem Cell 4-Marker Immunocytochemistry Kit (Thermo Fisher Scientific) in addition with the NANOG rabbit (Thermo, PA1-097) antibody.

### Pluripotency Teratoma Assay {#sec4.4.10}

The teratoma assay was done by EPO GmbH - Experimental Pharmacology & Oncology, Berlin, Germany. Briefly, in order to initiate the assay 1 x10^6^ cells were suspended in 50 ul of PBS and thereafter mixed with 50 ul of Matrigel (Corning). These cell suspension was than subcutaneously transplanted into a NOG-mice and the tumor growth was documented on a weekly basis. After reaching the size of 1,5cm^3^ the tumor was extracted and pathologically analyzed.

### Human ATAC-Seq {#sec4.4.11}

For ATAC-seq of human fibroblasts, 50.000 cells were harvested 48 h after siRNA transfection and the cell pellet was resuspended in transposase reaction mix as described previously ([@bib15]). Briefly, cell pellet was resuspended in the transposase reaction mix (25 μL 2× TD buffer, 2.5 μL transposase) using Nextera DNA Library Preparation Kit (Illumina) and the transposition reaction was carried out for 60 min at 37°C. The samples were purified using Zymo DNA Clean & Concentrator kit. Following purification, library fragments were amplified using NEBNext PCR master mix and previously published PCR primers ([@bib15]). Libraries were amplified for a total of 12 to 14 cycles and sequenced using paired-end-sequencing length of 75 nucleotides using NextSeq 500/550 High Output v2 kit (Illumina).

### *C. elegans* Nuclei Isolation and ATAC-Seq {#sec4.4.12}

For *C. elegans* ATAC-seq, L1 animals were synchronized by harvesting embryos using sodium hypochlorite treatment and grown on RNAi plates until L4 stage (P0 RNAi as described above). Generally, we performed ATAC-seq without inducing *che-1* overexpression in order to detect chromatin alterations that were caused by FACT depletion but not due to the activity of the reprogramming TF.

ATAC-seq upon RNAi against *hmg-4* and *spt-16* was performed in *glp-4(bn2)* mutant animals that lack a germline when grown at the non-permissive temperature ([@bib5]) to measure chromatin accessibility changes only in somatic cells. Synchronized L4 animals were washed 5 times in M9 buffer and collected on ice. Nuclei were isolated using a glass Dounce homogenizer with 50 strokes tight-fitting insert in buffer A (15 mM Tris--HCl pH7.5, 2 mM MgCl2, 340 mM sucrose, 0.2 mM spermine, 0.5 mM spermidine, 0.5 mM phenylmethanesulfonate \[PMSF\], 1mM DTT, 0.1% Trition X-100 and 0.25% NP-40 substitute) as described before ([@bib65], [@bib92]). The debris were removed by spinning at 100×*g* for 5 min and nuclei were counted by Methylene blue staining. 100.000 nuclei per sample were pelleted by spinning at 1000×*g* for 10 min and proceeded immediately to transposition step of the ATACseq protocol as described above ([@bib15]). For ATAC-seq analysis of gonad DNA, 20 wild type gonads were dissected per replicate and nuclei were isolated as described above. Libraries were amplified for a total of 10 to 18 cycles and sequenced using paired-end-sequencing length of 75 nucleotides using NextSeq 500/550 High Output v2 kit (Illumina).

### RNA-Seq Using *C. elegans* {#sec4.4.13}

For transcriptome analysis, RNA was isolated from HMG-4 and SPT-16-depleted animals using TRIzol (Life Technologies) and guanidinium thiocyanate-phenol-chloroform extraction. After adding chloroform to the sample containing TRIzol, phases were separated to an aquaous phase containing RNA, an interphase and an organic phase containing DNA and proteins. Guanidinium thiocyanate denatured proteins (including RNases) in the organic phase. RNA was purified from the aquaous phase using isopropanol. For reverse transcription GoScript Reverse Transcriptase (Promega) was used according to the manufacturers protocol. The preparation of libraries for whole-transcriptome sequencing was carried out using TruSeq RNA Library Prep Kit v2 (Illumina) according to the manufacturers instructions. Libraries were sequenced using single end sequencing length of a 100 nucleotides on a HiSeq4000 machine (Illumina). For transcriptome analysis of gonad RNA, 20 wild type gonads were dissected per replicate and RNA was isolated using Rneasy Micro Kit (Qiagen). PolyA-RNA enrichment was performed using oligo(dT)~25~ Dynabeads (Life Technologies) according to the manufacturers instructions. The libraries were prepared using NEXTflex Rapid Directional qRNA-Seq Kit (Bioo Scientific) according to the manufacturers instructions. The libraries were sequenced using paired end sequencing length of 75 nucleotides on a HiSeq4000 machine (Illumina).

### RNA-Seq Using Human Cells {#sec4.4.14}

For transcriptome analysis in hiF-T cells, RNA was isolated from 80.000 cells treated with control, SSRP1 or SUPT16H siRNAs 48 h after transfection using RNeasy Plus Mini Kit (Qiagen). To remove ribosomal RNA, Ribo-Zero Gold rRNA Removal Kit (Illumina) was used as described in the manufacturers protocol. ERCC spike-in control mixes 1 and 2 (Thermo Fisher) were used for normalization control and the libraries were prepared using NEXTflex Rapid Directional qRNA-Seq Kit (Bioo Scientific) according to the manufacturers instructions. Libraries were sequenced using paired end sequencing length of 75 nucleotides on a HiSeq4000 machine (Illumina).

### ChIP and ChIP-Seq {#sec4.4.15}

#### ChIP-Seq with Human Cells {#sec4.4.15.1}

For chromatin immunoprecipitation with sequencing (ChIP-seq), a batch of 25 million hiF-T cells were used per chromatin preparation. The cells were fixed with 1.1 % formaldehyde and iDeal ChIP-seq kit for Transcription Factors (Diagenode) was used for chromatin immunoprecipitation (ChIP) according to the manufactures instructions. The chromatin was sheared by sonication using the Bioruptor (Diagenode) for 20 cycles (30 sec on, 30 sec off) on high settings at 4°C. Go-ChIP-Grade anti-SSRP1mouse antibody (BioLegend) and anti-SPT16 (D7I2K) rabbit monoclonal antibody (Cell Signaling) were used for immunoprecipitation at 1:50 dilution. The libraries were prepared using NEXTflex® qRNA-Seq™ Kit v2 (Bioo Scientific) according to the manufacturers instructions. Libraries were sequenced using paired end sequencing length of 75 nucleotides on a HiSeq4000 machine (Illumina).

#### ChIP-Seq in *C. elegans* {#sec4.4.15.2}

M9 arrested L1 worms were grown on OP50/RNAi plates until L4/YA stage at RT. Animals were washed three times with M9 and fixed with 2% formaldehyde for 30 minutes followed by quenching with 0.125M glycine for 5 minutes. The samples were rinsed twice with PBS, and 100-200 ul of pellets were snap-frozen in liquid nitrogen and kept at -80°C. The pellets were washed once with 0.5 ml and resuspended in 1 ml FA Buffer (50nM HEPES/KOH pH 7.5, 1mM EDTA, 1% Triton X-100, 0.1 sodium deoxycholate, 150mM NaCl)+0.1% sarkosyl+protease inhibitor (Calbiochem) and then dounce-homogenized on ice with 30 strokes. The samples were sonicated using Bioruptor (Diagenode) with the setting of high power, 4°C, and 15 cycles, 30 sec on, 30 sec off. Soluble chromatin was isolated by centrifuging for 15 min at max speed at 4°C. The cellular debris was resuspended in 0.5 FA Buffer + 0.1% sarkosyl+protease inhibitor (Calbiochem) and sonicated again as described above. Isolated soluble chromatin was combined. The immunoprecipitation of HA- and AVI-tag proteins was performed overnight in a total volume of 600 μl with 4 μg of HA-antibody (ab9110, Abcam) and 80 μl of streptavidin coated dynamagnetic beads (Invitrogen), respectively, while 5% of samples were taken as input. Immunocomplexes with HA-tag were collected with Protein A-Sepharose beads (Sigma). The beads were washed with 1 ml of following buffers: twice with FA Buffer for 5 min, FA-1M NaCl for 5 min, FA-0.5M NaCl for 10 min, TEL Buffer (0,25M LiCL, 1% NP-40, 1% Sodium deoxycholate, 1mM EDTA, 10mM Tris-HCl pH 8.0) for 10 min, and twice with TE Buffer (pH8.0). DNA-protein complexes were eluted in 250 μl ChIP elution buffer (1%SDS, 250nM NaCl, 10 mM Tris pH8.0, 1mM EDTA) at 65°C for 30 min by shaking at 1400 rpm. The Inputs were treated for 5h with 20 μg of RNAse A (Invitrogen). The samples and inputs were treated with 10 μg of Proteinase K for 1h, and reverse cross-linked overnight at 65°C. DNA was purified with Qiagen MinElute PCR purification Kit (Qiagen).

The libraries were prepared using NEXTflex® qRNA-Seq™ Kit v2 (Bioo Scientific) according to the manufacturers instructions. Libraries were sequenced using paired end sequencing length of 75 nucleotides on a HiSeq4000 machine (Illumina).

#### Immunoprecipitation for Mass Spectrometry {#sec4.4.15.3}

Each immunoprecipitation was performed in triplicate. L4 staged wild type, *hmg-3*::*3xHA* and *hmg-4::3xHA* worms were collected and washed 4 times with M9 to get rid of bacteria. The worms were snap-frozen in liquid nitrogen and then cryo-fractured by using a pulverizer. In order to obtain a fine powder, worms were further ground using a mortar and pestle on dry ice. The worm powder was resuspended in 1.5x of lysis buffer (20mM Hepes pH 7.4, 150mM NaCl, 2mM MgCl2, 0.1% Tween20 and protease inhibitors), dounced with tight douncer 30 times and sonicated using a Bioruptor (Diagenode) (6 times 30 sec ON, 30 sec OFF; high settings at 4°C) followed by centrifugation at 16,000g at 4°C for 10 min. The supernatant was incubated with DNaseI (Thermo scientific) ON. Both control (N2) and IP (HMG-3::3xHA, HMG-4::3xHA) samples were incubated with HA antibody (ab9110, Abcam) for 30 min on a rotator at 4°C. Next, μMACS Protein A beads (Milteny Biotec) were added to samples as instructed in the kit, and samples were incubated for 30 min on ice rotating. Samples were diluted 5x with lysis buffer and μMACS columns (Milteny Biotec) were used to wash and elute the sample according to the manufacturers protocol. The proteins were eluted with elution buffer (100mM TrisCl pH 6.8, 4 % SDS, 20mM DTT) heated at 95°C. Eluted samples were prepared for mass spectrometry measurement by using SP3 ([@bib102]) before they were analyzed on a Q Exactive Plus (Thermo Scientific) connected to a Proxeon HPLC system (Thermo Scientific).

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

### ATAC-Seq Analysis {#sec4.5.1}

#### Pre-processing {#sec4.5.1.1}

ATAC-seq reads were trimmed for adapters using flexbar v2.5 (-f i1.8 -u 10 -ae RIGHT -at 1.0) ([@bib26]) and mapped with bowtie2 v2.0.2 ([@bib53]) in default paired-end mode and restricting pair distances to 1500 (-X 1500 \-- no-discordant) to version hg19 of the human genome or ce10 of the worm genome followed by removal of multimappers. PCR duplicates were removed using Picard Tools MarkDuplicates v1.90 (<http://broadinstitute.github.io/picard>) and reads were converted to .bed format using bedtools bamToBed v2.23 ([@bib76]). Pairs were filtered out if they mapped to the same strand, to different chromosomes, or if the 5'end coordinate of the -- strand read was less than or equal to the 5'end coordinate of the + strand read. Mapped pairs were split into single reads and converted to a 38-bp fragment reflecting the theoretical minimal spacing required for a transposition event by Tn5 transpososome ([@bib1]) using bedtools slop on the read 5'ends (-l 15 -r 22;) ([@bib76]). Replicates were concatenated after confirming high concordance. *C. elegans* datasets were further filtered for reads from the rDNA loci as well as those mapping to regions corresponding to transgenic reporter constructs existing in the strains and corresponding to sequences used in the RNAi vectors. See [Table S1](#mmc2){ref-type="supplementary-material"} for basic statistics.

### Peak Calling and Differential Analysis {#sec4.5.2}

Peaks were called on concatenated processed bed files using JAMM peakcaller v1.0.7.5 (-f38 --b 100 --e auto (human) and --e 1.75 (worm)) ([@bib42]). The resulting "all" (for meta analyses described below) or "filtered" peaks output by JAMM for each condition (control, SSRP1 knockdown, and SUPT16H knockdown for human, *rluc* and *hmg-3* knockdown, or rluc and *hmg-4, and spt-16* knockdown for worms) were concatenated and then merged with bedtools merge v2.23 ([@bib76]). Merged "all" peaks were further filtered for a minimum width of 25-bp and used for meta analyses as described below. Merged "filtered" peaks for human (totaling 106,967) and 25-bp width-filtered merged "all" peaks for worm (totaling 17,024 for the *hmg-4/spt-16* experiment and 21,254 for the *hmg-3* experiment) were then counted for the number of processed reads that intersected them from each replicate of each experimental condition using bedtools coverage v2.23 (-counts) ([@bib76]). Count tables were then normalized (method = "TMM") and subjected to differential analysis (exactTest) using edgeR ([@bib80]). Peaks were called as differential with a Benjamini-Hochberg adjusted p-value cutoff of 0.01 (adjust="BH").

### Peak Annotations {#sec4.5.3}

"Filtered" human ATAC-seq peaks or 25-bp width-filtered merged "all" ATAC-seq peaks for worm were annotated as promoter-proximal if they located +/- 200bp from human gencode v19 annotated start sites, or +/- 500bp from worm annotated TSSs, using bedtools closest ([@bib76]), otherwise they were considered promoter distal.

### *De Novo* Motif Generation and Scanning {#sec4.5.4}

For the human motif generation, promoter distal peaks were summed for their edgeR normalized log~2~ fold changes for each condition, split into two groups according to summed changes greater (opening peaks) or less than (closing peaks) zero. The resulting summed changes were used as the ranking statistic for motif generation using the cERMIT program (parameters: seed_length=6, min_motif_length=6, max_motif_length=12, required_core_length=5, cluster_sim_threshold=0.8, hypegeom_p\_val_cutoff=1.0e-30, num_random_runs=1000, max_gene_set_size_percentage_threshold=0.3, min_gene_set_size_percentage_threshold=0.01, degen_threshold=0.75, fraction_degen_pos_threshold=0.75, use_regression_scoring=no, bootstrap_motif_score=no, fast_mode=no; PMID: [20156354](pmid:20156354){#intref0145}). The same analysis was also done with the log~2~ fold change ranks separate for each factor.

Worm motifs were generated the same way, except independent of peak annotation and log~2~ fold changes were used individually for each factor knockdown as the ranking statistic for cERMIT. Sequences were restricted to those with lengths \<1000-bp and worm sequences for those \>50-bp and \<1000-bp prior to input into cERMIT. Sequence numbers put into cERMIT are as follows: human combined up 44068; human combined down 42720; SSRP1 up 45710, SSRP1 down 41087, SUPT16H up 42130, SUPT16H down 44667, *hmg-3* down 10653, *hmg-3* up 10486, *hmg-4* down 8721, *hmg-4* up 8221, *spt-16* up 8616, *spt-16* down 8326. cERMIT-generated motifs were converted to meme format and Tomtom ([@bib36]) was used in the default settings to match the generated motifs to the JASPAR CORE vertebrate 2016 database ([@bib58]) for the human motifs or to a published database of protein binding microarray-generated motifs for *C. elegans* ([@bib63]). Known binding preferences matching generated motifs were scanned using Speakerscan ([@bib60]) with a 500bp sliding local first-order markov background window and the maximum score taken for each peak.

### Fragment Length Analysis and Promoter ATAC-Seq Counts {#sec4.5.5}

Replicate-concatenated full-paired-end-fragments ATAC-seq .bed files were intersected with windows around annotated transcription start sites (see ChIP-seq section below) using bedtools intersect ([@bib76]) and the distribution of resulting fragment sizes summarized and plotted using geom_density from the ggplot2 suite ([@bib96]). The same windows were counted for processed ATAC-seq reads (see above) and the distributions plotted using geom_violin from ggplot2 ([@bib96]).

### Analysis of RNA-Seq {#sec4.5.6}

#### Human and Worm Gonad RNA-Seq {#sec4.5.6.1}

Unique molecular identifiers (UMIs) were extracted from .fastq files using UMI-tools ([@bib87]) and reads trimmed using fastx_trimmer from the FASTX-toolkit (<http://hannonlab.cshl.edu/fastx_toolkit/>). Reads were then filtered for ERCC spike-in reads and rRNA by mapping to a custom index with Bowtie 1 ([@bib54]).Trimmed, filtered, reads were then mapped using STAR ([@bib25]) to the hg19 or ce10 version genome builds and GTF files from GENCODE for human (V19 including an additional pre-mRNA transcript for each gene ([@bib62]) or from Ensembl for worms. Mapped .bam files were then subjected to PCR deduplication using UMI-tools ([@bib87]), followed by conversion to .fastq and remapping with STAR to generate final mapped files and normalized coverage tracks. Gene counts were quantified using RSEM ([@bib55]) and, for human, imported for differential expression analysis by DESeq2 (Love et al., 2014) using tximport ([@bib89]) and the DESeqDataSetFromTximport function within DESeq2. Genes were considered differentially expressed if they passed the DESeq2's independent filtering for both the supt16h knockdown and ssrp1 knockdown experiments and below the default FDR cutoff of 0.1 and one of the two experiments.

#### Whole Worm RNA-Seq {#sec4.5.6.2}

Multiplexed Illumina sequencing data was demultiplexed using Illumina bcl2fastq converter (version v2.17.1.14). Raw reads in fastq format were processed to get rid of low quality bases and possible adapter contamination using Trimmomatic (version 0.33) ([@bib10]) (settings: ILLUMINACLIP:TruSeq.fa:2:25:6 LEADING:3 TRAILING:3 SLIDINGWINDOW:4:15 MINLEN:36). The filtered reads were aligned to the *C.elegans* genome (ce10 genome build - WormBase WS220 released in October, 2010) using the splice-aware short read aligner STAR (version 2.4.2a) with the default settings ([@bib25]) except for setting "---outFilterMultimapNmax" argument to 1. The expression level of each gene was quantified using R/Bioconductor package quasR ([@bib31]) using genome annotation data in GTF file format from the Ensembl database (version 70) ([@bib99]) Differential expression analysis of the quantified expression levels of genes between different samples was done using the R/Bioconductor package DESeq2 ([@bib57]) Up/down regulated genes are detected based on the differential expression criteria of adjusted p-value of at least 0.1 and at least two-fold increase/decrease in expression levels in relation to the control samples.

### ChIP-Seq Analysis {#sec4.5.7}

Human Ssrp1 and Supt16h, as well as worm HMG-3::HA, ChIP-seq raw fastq files were extracted for UMIs using UMI-tools ([@bib87]) and then trimmed using fastx_trimmer from the FASTX-toolkit (<http://hannonlab.cshl.edu/fastx_toolkit/>). Reads were then mapped using bowtie2 ([@bib53]) and mapped reads selected for unique mapping prior to PCR deduplication using UMI-tools ([@bib87]). Uniquely mapped read pairs were then converted to .bed files reflecting coordinates of the full paired-end fragments using custom scripts and normalized bigwig files were generated on replicate-concatenated files using bamCoverage from the deepTools2 suite ([@bib77]). Input normalized final bigwigs were then produced using bamCompare from the deepTools2 suite ([@bib77]) setting the --ratio parameter to either "subtract" for the worm data or "ratio" for the human data. Annotated transcription start sites (TSS) were then quantified for ChIP signal by creating windows 500bp upstream and 1500bp downstream for human (250bp upstream and 1000bp downsteam for worm) and generating counts of full-paired-end-fragments from each replicate (the single input file for worms was split into two files to use as virtual replicates) using bedtools intersect ([@bib76]). These count tables were then subjected to "differential" analysis using DESeq2 with default settings comparing ChIP counts versus input counts. DESeq2 normalized log~2~ "fold changes" were used as ChIP-seq signal in these annotated window regions and genes were classified to have "high" signal if their respective annotated TSS window DESeq2 fold-change was greater than zero with an FDR of \< 0.1 and the gene passed the DESeq2 independent filtering from the accompanying RNA-seq data. Gene TSS windows were classified as ChIP-seq "Low" if they had an FDR \> 0.1 and the gene passed the DESeq2 independent filtering from the accompanying RNA-seq data. The use of the RNA-seq filter to define these two classes is intended to have a more comparable set of "Low" genes that are at least basally expressed within the system used. For the worm data, this RNA detection requirement for ChIP High and ChIP Low classes was taken from the whole worm RNA-seq data when plotting whole worm ATAC-seq data or assessing the relationship beween ChIP-seq level and whole worm RNA-seq fold changes following FACT knockdown, or was taken from the gonad-specific RNA-seq (requiring an FPKM \> 0 instead of DESeq2 filtering) for plotting gonad-specific ATAC-seq or assessing the relationship between ChIP-seq level and gene expression level.

### Meta-Analyses {#sec4.5.8}

All average profile and heatmap meta-analysis plots were performed on normalized bigWig files described above using the computeMatrix followed by plotProfile or plotHeatmap tools from the deepTools suite ([@bib77]).

### Density Scatterplots {#sec4.5.9}

All density scatter plots were generated using ggplot2 geom_hex (bins=50) ([@bib96]).

### Violin Plots {#sec4.5.10}

All violin summary plots were plotted using geom_violin (trim=TRUE, scale="width") from ggplot2 ([@bib96]).

### Enrichment Tests {#sec4.5.11}

For FACT knockdown RNA-seq enrichment tests with reprogramming gene clusters from Cacchiarelli et al ([@bib18]), ENSEMBL gene ids were obtained from the published clusters and intersected with ENSEMBL gene ids of the union of differentially increased or decreased genes upon FACT knockdown (see RNA-seq section above). The numbers of these intersections were compared to the Cacchiarelli gene cluster intersections with all genes that passed the DESeq2 independent filtering for both Ssrp1 knockdown and Supt16h knockdown datasets after filtering for common ids with the entire Cacchiarelli dataset. The built-in R function phyper was used with parameter "lower.tail=FALSE" to obtain enrichment pvalues from the hypergeometric distribution.

For ATAC-seq peak enichements with the Cacchiarelli clusters, all ATAC-seq peaks were assigned to the closest annotated TSS and the resulting ENSEMBL gene ids were filtered to remove genes that that did not pass DESeq2's independent filtering for both the Ssrp1 knockdown and Supt16h knockdown RNA-seq datasets (see RNA-seq analysis above). The unique union of genes assigned ATAC-seq peaks that were differentially increased or decreased for accessibility in either the Ssrp1 or Supt16h knockdowns was then intersected with the gene ids for each Cacchiarelli cluster and these numbers compared to the cluster intersections with the full set of RNA-seq-detected, ATAC-seq-peak-assigned genes after filtering for overlap with the entire set of Cacchiarelli ids. The pvalue from the hypergeometric distribution was calculated as described above.

Differential ATAC-seq and RNA-seq enrichments were tested as follows. Differentially regulated ATAC-seq peaks were assigned to the closest annotated TSS for each knockdown dataset and the resulting gene lists filtered to remove genes that had both increased-accessibility and decreased-accessibility peaks. For the human data, the union of increased-accessibility-peak-assigned genes and the union of decreased-accessibility-peak-assigned genes from the Ssrp1 knockdown and Supt16h knockdown datasets were generated. These two gene lists were then intersected with the union of up-regulated genes, the union of down-regulated genes, or the full set of genes that passed DESeq2's independent filtering from both the Ssrp1 and Supt16h knockdown RNA-seq datasets. The numbers of these intersections were used to calculate pvalues from the hypergeometric distribution as described above. For the worm datasets, each ATAC-seq and RNA-seq dataset was treated independently (rather than taking the union of differential genes/peaks) due to the whole worm aspect of the data and the observed distinct tissue expression domains of the FACT complex components. Otherwise, the approach was identical to that for the human datasets.

For enrichments of differentially regulated ATAC-seq peaks from worm FACT knockdown experiments with available transcription factor (TF) datasets, reproducible peak calls using the IDR approach were downloaded from the modENCODE/modERN website for ce10. Intersections were counted between sets of differentially regulated ATAC-seq peaks with the TF peaks using bedtools intersect ([@bib76]). These numbers were compared to the numbers of intersections for the same TF peaks with all ATAC-seq peaks and pvalues were obtained from the hypergeometric distribution as described above. For all enrichment tests, -log~10~ pvalues were plotted as heatmaps using the pheatmap package.

### GO Analysis {#sec4.5.12}

GO analysis was performed using PANTHER overrepresentation test ([@bib61]). The union of up- or down-regulated genes upon Ssrp1- or Supt16h-knockdown was compared to all genes detected in both experiments as a background and as output the PANTHER GO Slim ontologies.

### Mass Spectrometry Data Processing {#sec4.5.13}

Label-free quantification (LFQ) was performed using Max Quant and the data was analyzed with an online tool <http://projects.biotec.tu-dresden.de/msVolcano/> ([@bib86]).

### Other Statistical Analysis {#sec4.5.14}

Applied statistical analysis types used for phenotype scoring are indicated in the respective figure legends and Results section. Generally, the software application Prism (version 6, Graph Pad) has been used to calculate p-Values and determine standard deviations (SD) or standard error of the mean (SEM).

Data and Software Availability {#sec4.6}
------------------------------

The following link has been created to access to record [GSE98758](ncbi-geo:GSE98758){#intref0165} containing all ChIP-seq, RNA-seq and ATAC-seq data sets:

<https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=cnmnosmadlofpsz&acc=GSE98758>

Additional Resources {#sec4.7}
--------------------

### *C. elegans* Strains Used in the Study {#sec4.7.1}

Information on strains including genotypes are provided in [Table S7](#mmc1){ref-type="supplementary-material"}. All animals used for phenotype scoring were hermaphrodites.

### Sequences {#sec4.7.2}

Oligonucleotide sequences used for gene editing (CRISPR/Cas9) and qPCRs, and smFISH probe sequences are provided in [Table S8](#mmc1){ref-type="supplementary-material"}.

### ENCODE/modENCODE/modERN Files Used in This Study {#sec4.7.3}

Human CEBP ChIP-seq: ENCFF377MTQ.bamHuman H2AFZ ChIP-seq: ENCFF255USS.bigWigHuman H3K27ac ChIP-seq: ENCFF858MGD.bigWigHuman H3K4me3 ChIP-seq: ENCFF837XME.bigWigWorm ChIP-seq b0310.2_embryo: ENCFF230GNZ.bedWorm ChIP-seq elt-1_l3: ENCFF217KEA.bedWorm ChIP-seq elt-2_l3: ENCFF707HUO.bedWorm ChIP-seq fkh-6_embryo: ENCFF671ZAU.bedWorm ChIP-seq jun-1_l4: spp.optimal.JUN-1_OP234_WA_L4_IP_Rep0.tagAlign_VS_JUN-1_OP234_WA_L4_Input_Rep0.tagAlign.regionPeakWorm ChIP-seq pha-4_l4: ENCFF209ONL.bedWorm ChIP-seq skn-1_l4: ENCFF798LMX.bedWorm ChIP-seq unc-55_l2: ENCFF346FAK.bedWorm ChIP-seq ztf-16_embryo: ENCFF341MDZ.bed
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